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ABSTRACT

BIOCHEMICAL INVESTIGATIONS OF MACULAR DEGENERATION: THE
SIGNIFICANCE OF PROTEIN OXIDATION, INCLUDING NOVEL METHODS FOR
ITS STUDY

Sarah Warburton
Department of Chemistry and Biochemistry
Doctor of Philosophy

The retinal pigment epithelium (RPE) is a monolayer of cells located directly
behind the photoreceptor cells in the retina. These cells are involved in a variety of
functions that support the visual process in the eye, namely 1) they form a blood-retina
barrier which separates the neural retina from the choroid’s blood supply, 2) the apical
processes of RPE cells diurnally phagocytose the outer segments of photoreceptor cells,
and 3) they participate in the renewal of the photopigment 11-cis retinal.
Age-related macular degneration (AMD) is the leading cause of blindness in
people over the age of 50 years in North America and other developed countries. AMD
involves the death of retinal pigment epithelial (RPE) cells in the macula early in the
progress of the disease. Like some other postmitotic cells, the RPE accumulates
autofluorescent lysosomal storage bodies (lipofuscin) during senescence. Lipofuscin is
reported to begin accumulating in the human RPE around age 20 and continues to
accumulate throughout an individual’s life. This progressive accumulation of lipofuscin

can eventually occupy a substantial fraction of the RPE cytoplasmic volume and may
lead to impairment of normal RPE functions, resulting in retinal degeneration and loss of
visual function as in AMD. Another autofluorescent granule that accumulates in RPE
cells and may contribute to the etiology of AMD is a complex granule exhibiting
properties of both melanosomes and lipofuscin granules called melanolipofuscin (MLF).
In contrast with the accumulation of LF in the RPE, MLF accumulation has been reported
by Feeney-Burns to more closely reflect the onset of AMD.
Although there have been significant advances in our understanding of AMD,
knowledge of the mechanisms responsible for its progression remain unclear. This
dissertation details experiments that were designed to better understand the factors that
may play a causal role in AMD as well as the development of methods to assist in AMD
research. Specifically, the protein composition of retinal LF was assessed to elucidate its
origin. These findings are reported in chapter 2. The accumulation, composition and
phototoxicity of MLF were analyzed to assess MLF’s origin and possible contribution to
AMD. These results are reported in chapter 3. Because protein oxidation is possibly a
common posttranslational modification to proteins which accumulate in lipofuscin and
melanolipofuscin granules, a method for the detection and analysis of oxidized proteins
was developed and is reported in chapter 4. Chapter 5 details the proteomic differences
between ARPE-19 cells - the only human RPE cell line available for research - in their
differentiated and undifferentiated states and compares these to the proteome of human
RPE cells. These results are also compared to the phenotypic difference of these cells as
observed by transmission electron microscopy.
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CHAPTER 1
INTRODUCTION

Retinal Pigment Epithelium (RPE)
The retinal pigment epithelium is a monolayer of cells located directly behind
photoreceptor cells in the retina (Figure 1-1). During embryogenesis these cells
differentiate to form a polarized epithelium. Once epithelialized, RPE cells have little or
no turn over for the remainder of the organism’s life.
These cells are involved in a variety of functions that support the visual process in the
eye, namely 1) they form a blood-retina barrier which separates the neural retina from the
choroid’s blood supply, 2) the apical processes of RPE cells diurnally phagocytose the
outer segments of photoreceptor cells, and 3) they participate in the renewal of the
photopigment 11-cis retinal.

Figure 1-1. Cell layers in the retina. The retinal pigment epithelium (RPE) is located directly behind
photoreceptor cells in the retina. (picture from http://webvision.med.utah.edu/sretina.html )
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RPE forms a blood-retina barrier
Two sources supply blood to the mammalian retina: the central retinal artery and
the choroidal blood vessels. The choroid receives the greatest blood flow (65-85%) and is
vital for the maintenance of the outer retina. The remaining 20-30% flows to the retina
through the central retinal artery from the optic nerve to nourish the inner retinal layers
[Henkind, 1979]. Two highly selective blood-tissue barriers in the retina act to maintain
a highly regulated homeostatic environment within the specialized layers of neural tissue.
The outer blood-retinal barrier is established by RPE cells that lie adjacent to the outer
layer of the choroid. These cells are joined together near the apical side by tight
junctions, which block the free passage of water and ions. The RPE, therefore, plays a
critical role in regulating the volume and composition of fluid in the subretinal space
through the transport of ions, fluid and metabolites. [Steinberg and Miller, 1973;
Steinberg, 1985; Bialek and Miller 1994] This regulation is accomplished by specialized
transport proteins on the apical and basal surfaces of RPE cells.

RPE cells diurnally phagocytose photoreceptor outer segments
The outer segments of photoreceptor cells are composed of membranous discs
that contain the visual pigment opsin, necessary for initiation of the visual transduction
pathway. The photoreceptors are constantly exposed to oxygen and light, which facilitate
the production of free radicals and, over time, damage the membranous discs at the distal
end of each photoreceptor. Every day upwards of 100 discs at the distal end of each
photoreceptor are phagocytosed by the RPE, while new discs are synthesized (Figure 12). The number of photoreceptors overlying each RPE cell remains nearly constant, ~45
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photoreceptors per RPE cell.[Kennedy, 1995] This activity renders RPE cells the most
active phagocytes in the body. A deficiency in the RPE’s ability to phagocytose outer
segments contributes to retinal diseases including age-related macular
degeneration.[Edwards, 1977]

Figure 1-2. Phagocytosis of photoreceptor
outer segments by the RPE. The photoreceptors
are constantly exposed to oxygen and light
which facilitate the production of free radicals
and, over time, damage the membranous discs
at the distal end of each photoreceptor. RPE
cells diurnally phagocytose shed photoreceptor
outer segments, while new discs are
synthesized. This activity renders RPE cells
the most active phagocytes in the body.
Deficiency in the RPE’s ability to phagocytose
outer segments contributes to retinal diseases,
such as age-related macular degeneration.
(picture from Schraermeyer (1999) Pigment
Cell Research. )

RPE cells participate in the renewal of 11-cis retinal.
The phototransduction cascade in the retina is initiated when light isomerizes 11cis-retinal to all-trans-retinal, subsequently activating opsin. Because the turnover of 11cis retinal during daylight hours exceeds the amount of stored vitamin A in the retina, 11cis-retinal must be continually regenerated from all-trans-retinal. The RPE is involved in
the renewal of 11-cis retinal as part of a process referred to as the visual cycle. This
process begins when all-trans retinal is transported to the RPE where a series of enzymes
reisomerize the molecule to 11-cis retinal (Figure 1-3). 11-cis retinal is then transported
back to the photoreceptor cell and incorporated with opsin.
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Figure 1-3. Renewal of 11-cis retinal in the visual cycle. Because the turnover of
11-cis retinal during daylight hours exceeds the amount of stored vitamin A in the
retina, 11-cis-retinal must be continually regenerated from all-trans-retinal. This
process begins when all-trans retinal is transported to the RPE where a series of
enzymes reisomerize the molecule to 11-cis retinal. 11-cis retinal is then
transported back to the photoreceptor cell and incorporated with opsin. (picture
from Linus Pauling institute, Micronutrient Information Center
http://lpi.oregonstate.edu/infocenter/vitamins/vitaminA/visualcycle.html)

Age-related Macular Degeneration (AMD)
Age-related macular degneration (AMD) is the leading cause of blindness in
people over the age of 50 years in North America and other developed countries.
[VanNewkirk, 2001; Attebo, 1996; Klein, 1995; Bressler, 1988] AMD affects 2% of
individuals over 50 years of age and 30% of individuals over 75 years in the United
States.[Group, 1993] AMD involves the death of retinal pigment epithelial (RPE) cells in
the macula early in the progress of the disease. The macula, located in the central region
of the retina, is a highly sensitive area which provides the greatest visual acuity. It is a
circular area of approximately 6 mm diameter that is extremely dense in rods and cones;
containing 150,000 rods per mm2, whereas the peripheral retina has only 30,000
rods/mm2.[Jonas, 1992]
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Although increased age is the principal risk factor for AMD, studies have found
several other risk factors, including cigarette smoking, high cholesterol, hypertension,
cardiovascular disease, race, and family history. [Pieramici, 1998] A positive association
between smoking and neovascular AMD has been suggested in both men and women,
whereas an inverse association has also been found between dietary carotenoid intake and
AMD. [Control, 1992; Seddon, 1996; Hung, 1997] With the exception of age, however,
none of these studies has indicated a definite causal relation between a specific risk factor
and AMD.
The earliest morphologic feature of AMD is the development of extracellular
deposits, termed drusen, that accumulate between the basal lamina of the RPE and the
collagenous layer of Bruch’s membrane in the human eye. There are two phenotypes of
drusen termed “hard” drusen and “soft” drusen, each observed at different stages of
AMD. The first drusen deposits detected in the eye are “hard” drusen and are generally
round, possess distinct borders, and are comprised of homogeneous material.
The correlation between drusen and AMD is so firmly established that many
investigators and clinicians refer to the presence of “hard” drusen in the macula, in the
absence of vision loss, as “early AMD.” Drusen cause lateral stretching of the RPE
monolayer and physical displacement of the RPE from its immediate vascular supply, the
choriocapillaris.[Rones, 1937] This displacement may impede normal metabolite and
waste diffusion between the choriocapillaris and the neural retina. It has also been
suggested that drusen perturb photoreceptor cell function by placing pressure on rods and
cones and/or by distorting photoreceptor cell alignment. Drusen appear to affect various
aspects of vision prior to loss of visual acuity; these include changes in color contrast
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sensitivity, macular recovery function, central visual field sensitivity, and spatiotemporal
contrast sensitivity.[Midena, 1997; Tolentino, 1994; Frennesson, 1995; Midena, 1994]
Early AMD may progress into advanced AMD which has two forms: geographic
atrophy (GA) or “dry” AMD and choroidal neovascularization (CNV) or “wet” AMD.
GA accounts for 85-90% of all cases and is characterized by the formation of “soft”
drusen between the RPE and choroid (Figure 1-4). Soft drusen are larger than hard
drusen, have indistinct, sloped borders and are not usually homogeneous. Histologically,
they typically contain various inclusions and spherical profiles. Visual loss associated
with the appearance of soft drusen may be gradual, but results from atrophy of the RPE
and the overlying photoreceptors. CNV accounts for 10-15% of AMD cases and is
characterized by the growth of abnormal blood vessels either beneath the RPE or between
the RPE and the retina (Figure 1-4). Only rarely do the vessels extend through the RPE
and into the subretinal space. These abnormal blood vessels leak fluid and blood into the
tissue at the back of the eye, resulting in disciform scarring and further cell loss. Most
patients with active CNV will progress to visual acuity 6/60 or less within two
years.[Landy, 2003] In either form of AMD, loss of support to the photoreceptors brings
about eventual loss of vision. Currently, there is no established treatment for GA. Most
current therapies and new investigational treatments are directed at CNV. In selected
cases of wet macular degeneration, laser photocoagulation is effective for sealing leaking
or bleeding vessels. Unfortunately, laser photocoagulation usually does not restore lost
vision, but it may prevent further loss.
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Figure 1-4. Clinical diagnosis of the dry and wet forms of age-related macular
degeneration (AMD). Dry AMD is characterized by the formation of yellowish
deposits in the macula, known as drusen. Wet AMD is characterized by the formation
of abnormal blood vessels under the retina which leak fluid and blood into the tissue.
In either form of AMD, loss of support to the photoreceptors brings about eventual
loss of vision. ( picture from St. Luke’s Cataract & Laser Institute. Macular
Degeneration–Age-Related Macular Degeneration. www.stlukeseye.com/Conditions/
MacularDegeneration.asp.)

Oxidative Stress
Oxidative stress has been suggested to be a major contributing factor for retinal
degeneration in AMD. The retina is exposed to a relatively high oxygen pressure that is
close to that found in arterial blood. [Winkler, 1999] Both RPE and photoreceptor cells
in the retina are non-replicating (post-mitotic) and must respond to a lifetime of oxidative
insult, which includes light-induced oxidative stress. While there are numerous
mechanisms in the retina for preventing and combating oxidative injuries, by middle-age
many of these anti-oxidative mechanisms have begun to break down, which can increase
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the susceptibility of the retina to accumulated damage. Ultraviolet light is largely
excluded from passage to the retina by the cornea. However, visible light absorbed by
photoreceptors is a significant factor in the production of reactive oxygen species that
induce the molecular damage in retinal tissue which appears to contribute to the
formation of AMD. To an overwhelming degree, blue wavelengths of light produce the
most oxidative stress within the retina, because they are the most energetic photons to
reach the retina, and are primarily responsible for exacerbating the extent of oxidative
damage.
Studies have detected significant increases in oxidative modifications in
individuals with AMD when compared to those without. Free radical-induced oxidation
of docosahexaenoate-containing lipids generates omega-(2-carboxyethyl)pyrrole protein
adducts that were found to be more abundant in ocular tissues from AMD than normal
human donors.[Gu, 2003] Other oxidative protein modifications found to be more
abundant in AMD patients than in normal Bruch’s membrane include crosslinked species
of tissue metalloproteinase inhibitor 3 and vitronectin and carboxyethyl pyrrole protein
adducts.[Crabb, 2002] Carboxymethyl lysine, another oxidative modification, was also
detected in drusen.[Crabb, 2002] These data support the hypothesis that oxidative injury
contributes to the pathogenesis of AMD and suggest that oxidative protein modifications
may have a critical role in the formation of undegradable storage bodies, i.e. drusen,
lipofuscin, melanolipofuscin.

8

Lipofuscin Accumulation
Impairment of normal RPE functions is known to result in retinal degeneration
and loss of visual function as in AMD. It is therefore hypothesized that age-related
deterioration in RPE functions may lead to visual impairment. As a result, factors that
may be detrimental to RPE function have been studied to assess any possible contribution
to the deterioration of RPE function and vision loss. Like some other postmitotic cells,
the RPE accumulates autofluorescent lysosomal storage bodies (lipofuscin) during
senescence. Lipofuscin is reported to begin accumulating in the human RPE around age
20 and continues to accumulate throughout an individual’s life. This progressive
accumulation of lipofuscin can eventually occupy a substantial fraction of the RPE
cytoplasmic volume, as much as 20% by age 80.[Feeney-Burns, 1984] The composition
and origin of lipofuscin has not previously been completely established, but has been
thought to result from the accumulation of undigested material from the phagocytosis of
photoreceptor outer segments. Studies have indicated that the formation of lipofuscin
may be due to the oxidative alteration of macromolecules by free radicals, rendering them
undegradable by the cell.[Winkler, 1999]
It has been proposed that this accumulation of lipofuscin may be detrimental to
the RPE and possibly lead to loss of function and eventual vision loss because of its
ability to generate reactive oxygen species (ROS). Boulton et al. demonstrated that white
light irradiation of RPE lipofuscin granules results in the production of a variety of
reactive oxygen species (including superoxide anions, singlet oxygen, hydrogen peroxide
and lipid hydroperoxides), their rate of production increasing with increasing light
intensity.[Boulton, 1993; Rozanowska, 1995 & 1998] The effect was also shown to be
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wavelength dependent, with the greatest generation of reactive oxygen species in
granules exposed to blue light (400-520 nm). It has also been demonstrated that
lipofuscin causes blue light dependent cell death in cultured RPE cells.[Davies, 2001]
The ROS generated when blue light is absorbed by lipofuscin could damage cellular
DNA, lipoproteins, and other structures within RPE, and may lead to self-induced cell
death (apoptosis).
One constituent of retinal lipofuscin that may contribute to its phototoxicity is the
fluorophore A2E. A2E is a combination of two molecules of vitamin A aldehyde and one
molecule of ethanolamine which forms in photoreceptor outer segments and eventually
ends up in lipofuscin as the result of phagocytosis of discs in these segments.[Sparrow,
2000] A2E has been shown to generate ROS upon photosensitization with blue light and
cause blue light dependent cell death in cultured RPE cells.[Sparrow, 2000 & 2001]
Although A2E is the most studied photosensitizer of lipofuscin, it is not necessarily the
predominant photosensitizer.

Melanosomes in the RPE
RPE cells are highly pigmented due to a high concentration of melanin. Although
it has been generally accepted that dermal melanin protects the skin from UV light
damage [Kollias, 1991], the biological function of RPE melanin is not completely
understood. Melanin is known to absorb excess light passing through the eye, thereby
reducing scatter and improving image resolution. It has also been suggested to play a
photoprotective role in RPE cells [Sarna, 1992; Schraermeyer, 1999] by scavenging
reactive oxygen species [Dunford, 1995; Rozanowska, 1999; Sarna, 1985]. Evidence
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also exists for a phototoxic role for melanin in RPE cells, especially in aged cells,
including measurable ROS photoproduction [Boulton, 2001; Sarna, 1999; Rozanowski,
1999; Korytowski, 1986; Sarna, 2003]. Melanosomes have been observed to undergo
morphological and photophysical changes with age, possibly due to oxidation, which
may result in diminished antioxidant potential. Studies have reported that aged human
melanosomes are highly photoreactive and can result in RPE dysfunction, while young
melanosomes appear to confer photoprotection [Dayhaw-Barker, 2001; Gaillard, 2003;
Rozanowska, 2002]. With increasing age, a decrease in melanosomes in the RPE is
observed along with an increase in what seem to be melanosome-lipofuscin complexes,
termed melanolipofuscin (MLF). [Boulton, 1991; Feeney-Burns, 1978; Schraermeyer,
1994 & 1999].
Although little is known about the origin and composition of MLF, Feeney-Burns
et al. have reported that the accumulation of MLF more closely reflects the onset of AMD
than the accumulation of LF. Two models for the origin of MLF have been suggested.
The first model involves the autophagy of preexisting melansomes and their
incorporation into accreting LF granules. This model is supported by the observation that
phagosomes containing undegradable material fuse with melanosomes [Schraermeyer,
1999]. The second model is that melanin is synthesized de novo in lysosomes, which
subsequently fuse with accreting LF granules. This model is supported by evidence that
synthesis of melanin in depigmented RPE cells is seen in lysosomal compartments
[Dorey, 1990; Schraermeyer, 1994]. Knowledge of the composition of MLF could
provide significant insight into the origin of these granules, and determining the
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phototoxicity of these granules could be useful for ascertaining MLF’s role in the
etiology of AMD and other retinal diseases.

AMD Genetics
It seems likely that AMD has a multifactorial etiology, including environmental
stimuli, the impact of ageing and genetic predisposition. Genetic defects may render an
individual more susceptible to environmental insult or be sufficient to interrupt proper
visual functioning. Several studies have provided evidence for a genetic factor to AMD,
including Seddon et al. who evaluated first-degree relatives of AMD cases and control
individuals without AMD.[Seddon, 1997] The majority of the relatives evaluated were
siblings, although living parents and children over the age of 40 were also included. The
prevalence of AMD was significantly higher among first-degree relatives of AMD case
probands (23.7%) compared to that observed for first degree relatives of control probands
(11.6%).
Researchers have also studied the genome of patients suffering from retinal
degeneration to assess possible mutations that may contribute to vision loss. Patients
suffering from retinal degeneration were found to have heterozygous mutations in both
the ROM1 and RDS genes, whereas mutations in either of these genes alone had no effect
on phenotype. [Dryja, 1997] The products of both genes are membrane proteins that
localize to rod and cone photoreceptor discs, are structurally homologous, and associate
in vivo as a heterotetrameric complex both at the disc rims and at the site of disc
formation.
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AMD has several phenotypic similarities with Stargardt’s disease, including the
accumulation of drusen under the RPE and the progressive atrophy of RPE cells in the
macula. Stargardt’s disease is the most common form of hereditary, recessive macular
dystrophy, is characterized by juvenile-to-young-adult onset and is known to result from
a mutation in the ABCR gene. To determine if defects in ABCR contribute to AMD,
researchers screened for ABCR sequence alterations in two independent collections of
unrelated (n=96) and AMD (n=71) patients. Thirteen different AMD-associated
alterations, both deletions and amino acid substitutions, were found in one allele of
ABCR in 26 patients (16%).[Allikmets, 1997] The identification of a number of rare
variants in the ABCR gene in individuals with AMD suggests a possible contribution to
vision loss associated with AMD.
Another gene, responsible for an autosomal dominant form of Stargardt’s, was
recently identified as ELOVL4. Transgenic mice expressing a mutant form of ELOVL4
were shown to accumulate lipofuscin in their RPE which was followed by RPE atrophy.
RPE atrophy was proceeded by photoreceptor degeneration in the macula in a pattern
that resembles Stargardt’s and AMD.[Karan, 2005]
Researchers have also utilized gene knockout mice to assess genes implicated in
human retinal diseases. Most genes implicated in AMD have been shown to cause
accelerated accumulation of lipofuscin in RPE cells. However, again, the accelerated
RPE lipofuscin accumulation has not been shown to be the cause of the accompanying
macular degeneration. The lack of a definitive link between RPE lipofuscin accumulation
and AMD illustrates one of the biggest challenges remaining in lipofuscin research:
determining whether lipofuscin accumulation has an impact on cell function.
13

Dissertation Overview
Although there have been significant advances in our understanding of AMD,
knowledge of the mechanisms responsible for its progression remain unclear. My
dissertation details experiments that were designed to better understand the factors that
may play a causal role in AMD as well as the development of methods to assist in AMD
research. Specifically, the protein composition of retinal LF was assessed to elucidate its
origin. These findings are reported in chapter 2. The accumulation, composition and
phototoxicity of MLF were analyzed to assess MLF’s origin and possible contribution to
AMD. These results are reported in chapter 3. Because protein oxidation is possibly a
common posttranslational modification to proteins which accumulate in lipofuscin and
melanolipofuscin granules, a method for the detection and analysis of oxidized proteins
was developed and is reported in chapter 4. Chapter 5 details the proteomic differences
between ARPE-19 cells - the only human RPE cell line available for research - in their
differentiated and undifferentiated states and compares these to the proteome of human
RPE cells. These results are also compared to the phenotypic difference of these cells as
observed by transmission electron microscopy.

14

CHAPTER 2
LIPOFUSCIN ORIGIN & COMPOSITION

Summary
Several retinal diseases, including AMD, have been associated with the
accumulation of autofluorescent lipofuscin (LF) granules in the retinal pigment
epithelium (RPE). LF may relate to the onset of these ocular diseases because it has been
shown to generate reactive oxygen species via photosensitization with blue light, which
may cause damage and death of the RPE and surrounding cells. The origin of LF has not
been completely established, but the granules are thought to result from the accumulation
of undigested material from the phagocytosis of photoreceptor discs in RPE lysosomes.
To elucidate the origins of biologically active retinal lipofuscin (LF), proteins in this
granule were identified by limited-scale proteomic analysis using both two-dimensional
(2D) gel electrophoresis and SDS-PAGE coupled with MALDI-QqToF MSMS and
automated LCMSMS, respectively. Proteomic analyses identified 41 constituent
proteins. Hydrophobic proteins and several proteins specific to photoreceptors, including
rhodopsin, that have not previously been reported, were identified. Extensive protein
modification, especially oxidative damage, was observed. The proteins identified support
the model that LF accumulates in RPE cells as a result of the buildup of undigested
material from the phagocytosis of photoreceptor outer segments. Perhaps oxidative
damage renders some of these proteins indigestible and thus leads to the accumulation of
LF granules.
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Introduction
Several retinal diseases including age-related macular degeneration (AMD),
Stargardt's disease, and Best's macular dystrophy result from the degeneration of cells in
the retina. These diseases have also been associated with the accumulation of
autofluorescent lipofuscin (LF) granules in the retinal pigment epithelium (RPE) [Delori,
2001; Mata, 2000]. Many tissues accumulate LF granules, also called age pigments, but
the retinal LF that accumulates in RPE cells is probably unique. RPE cells are reported
to begin accumulating LF granules around age 20; and by age 80 these granules may
constitute up to 20% of the cell volume [Feeney-Burns, 1984]. LF may relate to the onset
of these ocular diseases because it has been shown to generate reactive oxygen species
via photosensitization with blue light [Beatty, 2000; Winkler, 1999; Rozanowska, 1995;
Wassell, 1999], which may cause damage and death of the RPE and surrounding cells.
LF is known to be a heterogeneous material composed of a mixture of proteins and lipids,
including several different fluorescent compounds. More than ten different fluorophores
from LF have been observed by thin layer chromatography [Feeney-Burns, 1983; Eldred,
1988] but the most fully characterized fluorophore is the bis-retinoid, A2E [Eldred,
1993]. One would expect to find an abundance of hydrophobic and highly modified,
microheterogenous proteins in LF granules because of their lipophilic nature and the
inability of RPE cells to degrade them. Recently another publication reported the
identification of proteins in LF granules using two-dimensional (2D) gel electrophoresis
[Schutt, 2002]. Due to the limitations of 2D electrophoresis including the lack of
solubility of hydrophobic proteins in buffer systems compatible with 2D gel
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electrophoresis, and the inability to focus microheterogeneous proteins into observable
spots, this method may limit the proteins amenable to identification.
The origin of LF has not been completely established, but the granules are thought to
result from the accumulation of undigested material from the phagocytosis of
photoreceptor discs in RPE lysosomes. The material is thought to be undegradable by the
cell, perhaps because of modifications that inhibit degradation. Knowledge of the
composition and origin of lipofuscin granules could be useful for designing therapies to
prevent lipofuscin accumulation and the onset of AMD. Elucidating the protein
constituents of LF could provide significant insight into the origin of these granules.
In this study we employed both one-dimensional (1D) and 2D gel electrophoresis to
provide a view of the proteins in LF, and demonstrated the presence of modifications on
these proteins. Our results are compared to a recent publication [Schutt, 2002] reporting
the identification of proteins in LF granules in which only 2D electrophoresis was
employed. Our findings provide strong evidence for the model that retinal lipofuscin
results from an accumulation of undigested material from the phagocytosis of
photoreceptor discs in RPE lysosomes, and also suggest a possible mechanism for the
inhibition of phagosomal/lysosomal digestion.

Materials and Methods
Lipofuscin isolation and fluorescence - Lipofuscin granules were isolated from human
RPE from donor eyes, provided by Dr. Paul Bernstein of the Moran Eye Institute,
(University of Utah, Salt Lake City, UT). We used RPE from human donor eyes provided
by the Utah Lions Eye Bank, after they had been released for research use. Any unused
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tissue was returned to the Eye Bank for proper disposal. No identifying information
beyond age, gender, brief ocular history, and cause of death was supplied to our
laboratory. All specimens were accepted without regard to gender, race, or ethnic origin.
No formal human subjects approval was required by the University for research studies
on donated human tissue (E4 exemption). The time between donor death and enucleation
was 1-4 h after which the donor eyes were stored at 4 °C until dissection. Dissections
were carried out 6-24 h after donor death in a dim light environment by Dr. Bernstein's
lab at the Moran Eye Institute. RPE's were shipped to BYU on dry ice and stored at -75
°C until use. RPE's from twenty randomly selected individuals between 20 and 80 years
of age were used for each preparation of isolated lipofuscin. The lipofuscin granules were
isolated using a sucrose gradient as described by Boulton et al. [Boulton, 1990].
Fluorescence spectra of isolated lipofuscin granules were acquired as described by
Boulton et al. [Boulton, 1990] using a Jobin Yvon Fluoromax-3 Spectrofluorometer
(Edison, NJ).

Bioactivity assay - ARPE-19 (human retinal pigment epithelial cells-ATCC-CRL-2302)
were grown in 96 well tissue culture plates and were maintained in RPMI 1640 media
supplemented with 10% fetal bovine serum (FBS). Cells were differentiated by
transferring them to Matrigel Basement Membrane Matrix (BD Biosciences, Bedford,
MA) and reducing the FBS in the media to 1% for two weeks. Upon differentiation, cells
were either maintained in RPMI 1640 media supplemented with 1% FBS or incubated in
the same media which also contained about 90 lipofuscin granules/cell for 24 h to allow
for ingestion of the granules. After the 24 h incubation, the lipofuscin-fed RPE cells were
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transferred back to RPMI 1640 media supplemented with 1% FBS and maintained for 7
days before use in bioactivity assay. To verify the bioactivity of the LF, differentiated
ARPE-19 cells that were fed LF or maintained as control cells were either subjected to
blue light (390-550 nm) for 24-48 h at an intensity of about 2.8 mW/cm or maintained in
the dark. Blue light was introduced into a humidified cell incubator using a Mille Luce
M1000 Fiber Optic Illuminator with a 150 W quartz halogen bulb, a 25 mm dichroic blue
light filter, and a 48 inch fiber optic cable which obviates heat damage (Edmund Optics,
Barrington, NJ). Photocytotoxicity of the lipofuscin granules was assessed using the
MTT Colorimetric Assay (Chemicon International, Temecula, CA). MTT (3-(4,5dimehtylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide) in PBS (pH 7.4) was added to
each well and then incubated at 37 °C for 4 h. After incubation, developing solution
containing 0.04 N HCl in isopropanol was added to each well and the absorbance was
read at 570 nm on a CERES UV900 HDi plate reading spectrophotometer (Bio-Tek
Instruments).

Microscopy - LF granules were prepared for scanning electron microscopy (SEM)
analysis by drying the granules on a silicon wafer and sputter coating them with gold.
The granules were analyzed on a Phillips XL30 ESEM FEG using a 5 kV accelerating
potential. For transmission electron microscopy (TEM) analysis LF granules were fixed
in glutaraldehyde, postfixed in osmic acid, dehydrated, and embedded in epoxy resin.
Slices of the sample (100 nm) were imaged and photographed on a JEOL JEM 2000 FX.
LF samples for atomic force microscopy (AFM) were prepared by drying the granules
onto a mica slide. Images were taken with a Multimode IIIa AFM instrument with
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microfabricated Si cantilever tips (Nanoscience Instruments, Phoenix, AZ). Vibrational
noise was dampened using an active isolation system (MOD1-M, Halcyonics,
Goettingen, Germany). Typical imaging parameters were: tip resonance frequency, 55-65
kHz; amplitude setpoint, 2.0-2.5 V; scan rate, 2.0 Hz. Images were processed offline to
remove the background slope using software bundled with the AFM instrument.

Total lipid determination in lipofuscin - Lipofuscin granules were collected by
centrifugation and dried in an evaporative centrifugal concentrator. The granules were
weighed using a Mettler UMT2 microbalance (Columbus, OH) to determine the total
mass of the granules. After weighing the dried granules, lipids in lipofuscin samples were
extracted in chloroform:methanol (2:1, v/v). The lipid extract was dried in an evaporative
centrifugal concentrator and weighed using the microbalance to determine the total mass
of lipids.

Total protein determination in lipofuscin - After weighing samples of lipofuscin granules
as above, the protein in these lipofuscin samples was quantified by solubilizing 150 μg of
lipofuscin protein (about 380 μg lipofucin) in 30 μl of 1% (w/v) SDS followed by the
BCA Protein Assay (Pierce, Rockford, IL).

2D Gels - LF granules containing 300 μg of protein were collected by centrifugation at
6000x g and solubilized in reswelling buffer (7 M urea, 2 M thiourea, 15 mM
dithiothreitol (DTT), and 1% pharmalites) with either 4% Triton X-100 or 0.5% Triton
X-100 and 2% ASB-14 (Calbiochem, San Diego, CA). Both cuploading and reswelling
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procedures were used to analyze the proteins. Isoelectric focusing was performed using a
7 cm immobilized pH gradient (IPG) pH 4-7 on a Multiphor II Electrophoresis System
(Amersham Pharmacia Biotech, Piscataway, NJ). A programmed voltage gradient was
used consisting of 200 V for 1 min, linearly increasing to 3500 V over 1.5 h, and held at
3500 V for 1.5 h to reach a total of approximately 8 kVh. Following isoelectric focusing,
IPG strips were washed in equilibration buffer (0.05 M Tris, 6 M urea, 30% glycerol, and
1% SDS) containing 32 mM dithiothreitol for 15 min followed by a 15 min wash in
equilibration buffer containing 216 mM iodoacetamide. The proteins were then separated
according to their molecular weight on a 10% gel (8.3x6.4x0.1 cm) using standard SDSPAGE conditions. Gels were stained with colloidal coomassie (Pierce), and were
analyzed using Melanie 4 software (GeneBio, Geneva, Switzerland [Verhaert, 2001]).
Internal pI and molecular weight standards were used to assist in alignment of gels.
Excised spots were trypsinized in-gel [Shevchenko, 1996] and desalted using a ZipTipUC18

(Millipore, Bedford, MA). Sample spots of 1 μl were allowed to co-crystallize on the

MALDI plate with 1 μl of α-cyano 4-hydroxycinnamic acid as the matrix. Peptides were
analyzed by oMALDI Qq-ToF (orthogonal matrix-assisted laser desorption ionization
quadrupole time-of-flight) mass spectrometry on an Applied Biosystems QSTAR Pulsar i
instrument (Foster City, CA).

1D Gel and mass spectrometry - Lipofuscin granules containing 100 μg of protein were
collected by centrifugation, solubilized in 20 μl 4X Laemmli buffer (3% SDS, 0.17 M
Tris pH 6.8, 35% glycerol, 3.5% 2-mercaptoethanol) and separated on a 10% SDSpolyacrylamide gel (8.3x6.4x0.1 cm). The proteins were in-gel digested as described by
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Shevchenko et al. [Shevchenok, 1996], injected onto a Jupiter C18 reversed-phase resin
capillary column (150 μm IDx20 cm, made in-house) and eluted using a gradient of 5 to
95% acetonitrile in 0.1% formic acid at a flow rate of 5 μl/min. On-line mass
spectrometric analysis was performed on an Applied Biosystems QSTAR Pulsar i using
an atmospheric pressure ionization (API) source. Automated tandem mass spectrometry
using information-dependent acquisition was run, collecting collision induced
dissociation (CID) spectra for the three most intense ions from each survey scan
excluding peaks chosen in the preceding 2 min. Fragmentation spectra were chosen by
hand for submission to the Mascot (Matrix Science) website for peptide identification.
The ProID extension of BioAnalyst (Applied Biosystems, Foster City, CA) was also used
to identify modifications on RLF proteins.

Immunoelectron microscopy - Granules were collected by centrifugation and fixed with
either 2% glutaraldehyde or 2% paraformaldehyde. The granule pellets were dehydrated
in ethanol and embedded in LR White resin, one of the most infiltratable resins
specifically designed for immunocytochemical techniques. Slices of the samples (100
nm) were collected on formvar-coated gold grids. Grids were incubated first in 4%
bovine serum albumin (BSA) for 15 min at room temperature to block nonspecific
binding sites, then in either a 1:1000 dilution of anti-rhodopsin IgG (R4, polyclonal
antibody Takemoto et al. [Takemoto, 1985]) or anti-phosducin IgG [Thulin, 1999]
(negative control) overnight at 4 °C, and finally a 1:100 dilution of anti-rabbit IgG goldconjugate (10 nm, Sigma, St. Louis, MO) for 2 h at 37 °C. Between each incubation
period the grids were washed four times for 2 min each in either Tris Buffer A pH 8.2
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(200 mM NaCl, 20 mM Tris, 1% NP40, 0.05% Tween 20) or Tris Buffer B pH 8.2 (200
mM NaCl, 20 mM Tris). The grids were stained with uranyl acetate and lead citrate prior
to examining them on a FEI Tecnai 12 (Hillsborough, OR) transmission electron
microscope. Micrographs from two samples were used in the analysis, one sample was
fixed with paraformaldehyde and washed with Tris Buffer A and the other sample was
fixed with glutaraldehyde and washed with Tris Buffer B. Because fixation of the sample
requires alteration of protein constituents, this process can block or impede antigen
labeling. Therefore, different fixation procedures were explored to ensure appropriate
labeling of the sample. The gold particles, associated with the RLF granules and the resin
(nonspecific binding), in the micrographs were counted in a total area of about 120 μm2
containing about 100 granules. Adobe Photoshop was used to determine the area
occupied by granules and resin in the micrographs. The area occupied by granules and
resin was normalized to half of the total area. That normalization was applied to the gold
particle count to accurately determine the fraction of gold particles bound to RLF
granules.

Flow cytometric analysis - To determine the size distribution and concentration
(granules/unit volume), suspensions of LF granules were diluted 1:100, and 1:1000 with
PBS, and 200,000 Flow Check High Intensity Green Alignment Beads (Polysciences,
Inc., Warrington, PA), 5.726±0.375 μm in diameter, were added to each sample to serve
as an internal standard. The samples were excited with an argon laser at 488 nm on a
Beckman Coulter (Beckman, Fullerton, CA) EPICS-XL Flow Cytometer with EXPO 32
ADC software for flow cytometric analysis. The samples were analyzed for light scatter
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and autofluorescence by collection of data for 300 s, which allowed visualization of at
least 5,000 beads and at least 49,000 LF granules.

Immunoblots -Human retinas were obtained from Dr. Paul Bernstein from the Moran Eye
Institute to provide a positive control for rhodopsin. A retina was gently triturated in 0.75
M sucrose, 0.68 mM CaCl2, 20 mM Tris and 1 mM DTT, pH 7.4 to rupture the cells. The
suspension was poured over 4 thicknesses of cheesecloth to remove cellular debris. The
sample was centrifuged at 1475x g for 20 min and the pellet was resuspended in 1% SDS.
Total protein was determined using the BCA assay.
Anti-rhodopsin antibody (R4) was used at 1:1000 dilution in Tris buffered saline with
0.05% (w/v) Tween (TBS-T). Anti-CRALBP antibody (Dr. John C. Saari, University of
Washington, Seattle, WA) was used at a 1:1000 dilution in TBS-T. LF protein (30 μg)
was separated on a 1D gel and analyzed for malondialdehyde (MDA)-modified proteins
using a rabbit antibody to MDA (Calbiochem, San Diego, CA) diluted 1:1000 in TBS-T.
Oxidized BSA standards were made by incubating BSA in hypochlorous acid at 37 °C
for 30 min. LF and BSA samples were derivatized by incubating them in 5% sodium
dodecyl sulfate and 10 mM 2,4-dinitrophenylhydrazine (DNP) in 10% (v/v)
trifluoroacetic acid for 30 min at room temperature [Shacter, 1994]. Laemmli buffer and
2 M Tris base was added to the samples until they turned from yellow to blue, indicating
that the pH was neutral, before loading the samples onto a gel. Anti-DNP antibody from
rabbit was used at a 1:1000 dilution (Sigma, St. Louis, MO).
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Results
LF granules, isolated as previously described [Boulton, 1990], were found to be
biologically active in retinal pigment epithelial (RPE) cells in culture (Figure 2-1).
Several physical measurements of LF granules were made, including electron
microscopy, atomic force microscopy, and size distribution using flow cytometric
analysis (Figure 2-2). Fluorescence spectra from our LF preparations (Figure 2-3, top
panel) showed extensive similarity to those published by Boulton et al. [Boulton, 1990]
(Figure 2-3, middle panel), with a broad excitation maximum between 350 and 450 nm
and a broad emission maximum near 600 nm. Figure 2-3 also shows a comparison to
excitation and emission spectra recently reported from Schutt et al. [Schutt, 2002], which
show a narrow excitation peak at 350 nm and a narrow emission peak at 450 nm.
Because the LF fluorescence spectra generated by Boulton et al. looks more similar to the
fluorescence spectra of A2E than LF granules we would speculate that somewhere in
their procedure they separated the lipids and the proteins.
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Figure 2-1. Bioactivity of lipofuscin (LF) granules. Isolated LF granules were fed
to differentiated ARPE-19 cells which were then allowed to recover for 7 days.
Cells that were not fed LF were used as controls. Cells were then subjected to blue
light irradiation (solid black or grey bars), or left in the dark (cross-hatched or open
bars), for 24 to 48 hours as described in the text. Cell viability was determined
using the MTT assay. Values represent means of eight to twelve independent
measurements, error bars representing standard deviation.

Transmission and scanning electron microscopy (TEM and SEM) as well as atomic force
microscopy (AFM) were employed to examine the structure of LF. TEM (Figure 2-2B)
shows granules of approximately 0.7 μm in diameter of fairly uniform density, as has
been previously reported [Eldred, 1988; Sohal, 1986; Boulton, 1986]. Despite this
apparent uniform density and rather simple circular cross-section, SEM (Figure 2-2C)
shows that these granules are mostly spherical but appear to have some globular surface
features that suggest aggregation. The aggregate nature of LF is best illustrated by AFM.
Figure 2-2C shows AFM phase images of two granules. In one (top panel), surface
globules of about 200 nm diameter, noted in SEM, are seen and would seem to suggest
growth by accretion. In both this picture and the other AFM view (Figure 2-2C lower
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panel), LF appears to be made of smaller (about 50 nm) structures that are aggregated
together.

B

A

C

1μm

1μm

1μm
1μm

Figure 2-2. Microscopy of lipofuscin granules. A: Transmission electron micrograph of LF, showing
granules of homogeneous density. B: Scanning electron micrograph of LF, showing nearly spherical
granules with some surface features. C: Atomic force micrographs (phase images) showing LF granules
to be aggregates of about 200 nm (upper panel) and about 50 nm (both panels) substructures.

Taken together, the microscopic analyses show LF granules to be composed of smaller
structures of fairly uniform density that have accreted together to form the granules
themselves. Granule size was more quantitatively determined using flow cytometric
analysis (FC). Forward light scatter in FC instruments is directly proportional to the size
of the objects passing through the beam. The LF granules were found to be distributed
into two populations by size, one (representing 99% of the granules) having a mean
diameter of 0.69 μm with a Gaussian distribution and a broad standard deviation of 0.63
μm, and the other population (representing only 1% of the granules) having a mean
diameter of 4.8 μm with standard deviation of 0.3 μm. Flow cytometry also enabled a
quantitative determination of the concentration of granules in our suspensions. Having a
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quantitative count of the LF granules we were able to determine their average weight,
which proved to be 1.3±0.2 pg/granule.
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Figure 2-3. Fluorescence of lipofuscin
granules (LF). Fluorescence spectroscopy
of LF from our preparations (top panel)
compared with LF from Boulton et al.
[Boulton, 1990] (middle panel) and Schutt
et al. [Schutt, 2002] (lower panel). The
spectra from their published papers were
simply traced. Excitation (gray) monitored
with emission at 570 nm, and emission
(black) monitored with excitation at 364
nm. These spectra provide evidence that
supports the congruence of our
preparations with those studied by Boulton
et al. [Boulton, 1990].
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To determine the composition of the granules, first the lipids from a weighed
quantity of granules were extracted in methanol:chloroform, transferred, evaporated to
dryness and weighed. This revealed that LF was 49.5%±1.1% extractable lipid by weight.
These percentages represent the mean of three independent measurements and indicate
the standard deviation. Next, the protein in a known quantity of LF was solubilized in 1%
SDS and quantified by BCA assay. LF consisted of 43.5%±2.6% total protein. Thus,
these granules were composed nearly entirely of lipid and protein. These percentages
represent the mean of three independent measurements and indicate the standard
deviation.
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In order to analyze the protein component of LF, the granules were subjected to
2D gel electrophoresis. Initial attempts yielded very few protein spots. Only after loading
significantly more protein (300 μg) than would typically be needed to examine an entire
cell extract (about 100 μg total protein) were significant numbers of spots visible (Figure
2-4A).
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Figure 2-4. Electrophoresis of lipofuscin (LF) proteins. A: 2D electrophoresis gel from 300 μg of LF protein.
This gel is representative of gels from four separate LF preparations. Spots found in at least three of the four
gels are indicated by their identifying spot number (Table 1). Spots lacking a label were unique to this
particular preparation. Spots from standard proteins used to align gels are indicated as "std A" and "std B". B:
Representative lane of SDS-PAGE of 50 μg of LF protein. Mobilities of molecular weight markers are
indicated to the left. On the right, gel slices taken for subsequent in-gel digestion are shown. The 1D gel shows
relatively few well-resolved bands with much diffuse protein staining; thus 6 fold more total protein is needed
in the 2D gel in order to observe a surprisingly small number of well-focused protein spots. Taken together,
these observations suggest that the proteins of LF are notably heterogeneous.

2D gel electrophoresis of LF proteins using a common isoelectric focusing buffer that
contained 4% Triton X-100 resulted in 37% fewer spots than when the same sample was
run in buffer with 0.5% Triton X-100 and 2% ASB-14 (data not shown). ASB-14 is a
zwitterionic detergent known to facilitate the entry of transmembrane and other
hydrophobic proteins into 2D gels [Santoni, 2003]. The results reported were obtained
using ASB-14 in the reswelling buffer.

29

A)

230.1216
40
35

159.0756

30
Intensity, counts

25
20
15

86.0958
197.1237
315.2063 507.2285
424.2283 571.2303

10

1092.5236
783.3502 960.4231
1156.6824
684.4435

5
0

B)

23
22

847.3414

200

400

600
m/z, amu

800

1000

1200

358.1467
244.0983

20
18
16 175.1246

1602.8731

Intensity, counts

14
12
10

570.2973
683.3977
538.3066
375.2333
666.3535

1274.6852

228.1335

8
6

457.2180

4

919.4839
772.3577

1257.6949
1129.6236

1584.8456

2
0

200

400

600

800
1000
m/z, amu

1200

1400

Figure 2-5. Mass spectrometry of
peptides from lipofuscin proteins. A:
CID spectrum from LCMSMS of the
peptide identified as
SAAIYNPVIYIMO2MONK (where MO
represents Met sulfoxide and MO2
represents Met sulfone) from rhodopsin.
Indicated in bold are six y ions that make
identification of these modified sites
unequivocal. Another spectrum showed
the same peptide with Met sulfoxide at
the first Met position, and a third
spectrum showed Met sulfone at the first
Met without Met sulfoxide at the second
Met position (data not shown). B:
Representative CID spectrum from
oMALDI MSMS. This peptide was
identified as LVDQNIFSFYLSR from
cathepsin D. The spectrum in A allows
the conclusive identification of the
modified methionines at positions 308
and 309 of rhodopsin. These spectra
show that the fragmentation data
obtained by both LCMSMS and
oMALDI MSMS are of sufficiently high
quality to allow unambiguous
identification of the corresponding
peptides.
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2D gels were run analyzing proteins from four independent preparations of LF granules.
These gels showed some variation in number of spots, ranging from 53 to 121 (with an
average of 78.5 spots per gel). The image processing program Melanie 4 was used to
compare and match spots from the different gels. A "synthetic gel" was constructed in
silico using this software, where each spot in the synthetic gel represented a spot present
in at least three of the four 2D gels. Forty-four spots were found in the synthetic gel,
including the five internal pI standards that had been added before electrophoresis.
Nineteen proteins were identified from the 2D gels, corresponding to 37 of the 39 spots
(some proteins run as more than one spot due to posttranslational modifications).
Because of the limitations of 2D electrophoresis, we also analyzed LF proteins
that had been solubilized in 1% SDS using 1D SDS-PAGE (Figure 2-4B). The overall
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pattern of bands seen in Figure 2-4B was qualitatively reproducible from one preparation
of LF granules to another. Regions of the 1D gel were cut out and trypsinized for
subsequent analysis and protein identification using HPLC with on-line ESI-QqToF
tandem mass spectrometry (LCMSMS) techniques (Figure 2-5A). These protein
identifications were compared with those for proteins from spots in the 2D gels, which
were excised, trypsinized, and identified using MALDI-QqToF mass spectrometry
(Figure 2-5B).
retina
standard
2μg

A)

RLF
1μg

RLF
3μg

RLF
10μg

retina
standard
2μg

118 kDa
86 kDa

Figure 2-6. Rhodopsin immunoblots
of lipofuscin (LF). A: Immunoblot
following SDS-PAGE of 1, 3, and 10
μg of total LF protein. Shown for
comparison is 2 μg of protein from
photoreceptor cell membranes
enriched from human retina.
Rhodopsin runs on SDS-PAGE as a
mixture of the monomer (about 30
kDa), dimer (about 60 kDa), and
trimer (about 90 kDa). B: Immunoblot
following 2D electrophoresis of 10 μg
of total LF protein. For comparison,
10 μg of LF protein was loaded in the
standards lane of the second
dimension gel. The diffusion (band
broadening, due to modifications) of
the rhodopsin in LF as compared with
that in photoreceptor cells indicates
that the rhodopsin in LF is remarkably
heterogeneous.

47 kDa
34 kDa
26 kDa
19 kDa

B)

RLF
10μg

Twenty-seven proteins were identified in 1D gel regions (Table 2-1), including
five that were also found in the 2D spots. Thus, 22 proteins were identified in 1D gel
regions that were not identified in the 2D gels. Notably, though 27 proteins were
identified, many good quality CID spectra (defined as spectra that have at least four
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fragment peaks of signal:noise >5 between 500 and 1300 m/z) did not yield credible
protein identification.
Figure 2-7.
Immunocytochemistry of
lipofuscin (LF). LF granules
were fixed and embedded in
resin. Thin sections were
collected on gold grids,
incubated with an antirhodopsin antibody, washed,
incubated with gold-conjugated
protein A, washed, and
examined using transmission
electron microscopy (TEM).
TEM showed gold-conjugated
protein A bound to antirhodopsin antibodies on the LF
granules as dark black dots,
which have been pseudocolored
red. Rhodopsin is an integral
part of the LF granules.

Among the proteins identified in 1D gel regions but not in the 2D gels was
rhodopsin. Because of its importance and abundance in the photoreceptor cells which are
phagocytosed by the RPE, we examined the rhodopsin in LF further. Figure 2-6 shows
immunoblot analyses of both 1D and 2D separations of LF proteins, probed with an
antibody raised against rhodopsin. In both of these blots, the microheterogeneity of the
rhodopsin population in LF was evident. The 2D immunoblot explains why no rhodopsin
was identified from the 2D gel, since no well-focused spots were observed. This is
despite the apparent abundance of LF rhodopsin, based on the 1D immunoblot. Some of
the modification responsible for the observed heterogeneity of LF rhodopsin was
determined to be oxidative damage. The tryptic peptide containing Met308 and Met309
was found by mass spectrometry bearing one, two, and three extra oxygen atoms which
MSMS localized to the tripeptide IMM, residues 307-309 of rhodopsin, indicating
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oxidation of one or both of these Met residues to the Met sulfoxide or even the Met
sulfone (Figure 2-5A). Rhodopsin was further confirmed to be a component of LF
granules by immunocytochemistry. Electron micrographs of LF showed gold-conjugated
protein A bound to anti-rhodopsin antibodies on the LF granules (Figure 2-7). Over twothirds of the gold particles in these micrographs were found on LF granules when
corrections were made for the total area within and between granules.
Another protein of significant interest was the cellular retinoid binding protein
CRALBP, which can be used as a molecular marker for RPE cells [Schlunck, 2002].
CRALBP was not identified in 1D gel slices of LF proteins, but was identified by mass
spectrometry from a lower abundance spot seen in one of the four 2D gels. 1D
immunoblots showed that while CRALBP was present in LF protein extracts, it was not
very abundant (Figure 2-8).
standard
15.25 μg

RLF
1μg

RLF
3μg

RLF
10μg

RLF standard
50μg 15.25 μg

Figure 2-8. CRALBP
immunoblot of
lipofuscin (LF). Doses
of 1, 3, 10, and 50 μg
total LF protein were
run on SDS-PAGE and
blotted with an antiCRALBP antibody.
Shown for comparison
are 15.25 μg of total
protein extracted from
human RPE. CRALBP
is nearly absent from
LF.

118 kDa
86 kDa

47 kDa

34 kDa

26 kDa

19 kDa

In light of the oxidation seen on rhodopsin, and in view of the hypothesis that oxidative
damage may be involved in the generation of LF, we examined the LF proteins for
oxidative modifications using DNP, which derivatizes protein carbonyls [Shacter, 2000].
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Figure 2-9A shows an immunoblot of DNP-derivatized LF proteins using an anti-DNP
antibody which binds to the hydrazones formed by derivatization of the oxidatively
formed carbonyls. Additional immunoblots revealed LF proteins containing lipid
peroxidation- or glucoxidation-induced damage, specifically malondialdehyde (MDA,
Figure 2-9B), and advanced glycation end products (AGE), respectively.

A)

BSA BSA BSA RLF RLF RLF
0.2μg DNP HOCl 1.4μg 4μg DNP
1.4 μg
0.2μg DNP
0.2μg

RLF
DNP
4 μg

118 kDa

B)

α-MDA
30 ug
RLF

α-AGE
150 ug
RLF

118 kDa

86 kDa

86 kDa

47 kDa

47 kDa
34 kDa

34 kDa
26 kDa

26 kDa
19 kDa

Figure 2-9. Immunoblots of oxidatively damaged lipofuscin (LF) proteins. A: LF proteins, 1.4 and 4
μg, that had been derivatized with dinitrophenyl hydrazine (right two lanes) or that were untreated
(middle two lanes) were run on SDS-PAGE and blotted with an anti-DNP antibody to show the
derivatized protein carbonyls, a common product of protein oxidative damage. Shown for comparison
and to demonstrate specificity are lanes of BSA, BSA treated with DNPH, and BSA oxidized with
hypochlorite then treated with DNPH. B: 30 and 150 μg of LF proteins were separated using SDSPAGE and blotted with an anti-MDA antibody to show LF proteins containing lipid peroxidationinduced damage. There is extensive oxidative damage to LF proteins.

Protein oxidation was seen to be extensive (proteins across the molecular weight range of
the 1D gel were seen to be modified) in the anti-DNP immunoblot. Notably, no wellfocused spots of DNP-labeled proteins were detected in 2D immunoblots (data not
shown). This suggests that many proteins that were oxidatively damaged were too
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heterogeneous to be observed in 2D gels, and therefore cannot be identified using this
kind of separation.
Table 2-1. Proteins identified in lipofuscin granules. These proteins were identified from in-gel digestion
followed by mass spectrometry from the respective SDS-PAGE gel regions or 2D gel spots. These proteins
demonstrate that LF contains components of photoreceptor discs and of lysosomes. Furthermore, 1D- and
2D-based protein identification is complementary, with 1D-based methods identifying significantly more of
the heterogeneous and hydrophobic proteins that are found in LF. We could not differentiate between
creatine kinase and arginine kinase because of identical peptide sequences. KIAA0617 was only identified
from one peptide with relatively low confidence. Items marked with an asterisk (*) were previously
reported by Schutt et al. [Schutt, 2002].
Protein

GenBank
Number

Gel
Area/
Spot #

4F2 antigen
heavy chain

177207

D2

11-cis retinol
dehydrogenase

2492753

I

acyl-CoA
dehydrogenase

3273228

F

alpha 1antitrypsinI

24438

H

alpha-tubulin 4II

32015

A, D2

alpha-tubulin 1III

37492

F

anion transport
proteinI

28714

D1

annexin A2II, III

18645167

A

beta-globinI,III

29446

B

calnexinII

2134858

E1

cathepsin DII, III
Ceroidlipofuscinosis
cytochrome c
oxidase II subunit

494296
5729770

B
H

14016

L

Interphoto-

33961

D1

Tissue
Specificity

Subcellular
Location

Alternate
Names

Gene
Ontology

type II
membrane
protein
membraneassociated

CD98
antigen

calcium ion
/ amino acid
transport
visual
perception

1D Gel

retinal
pigment
epithelium

mitochondrial
inner
membrane
extracellular

plasma

erythrocytes

integral
membrane
protein
membrane
associated

erythrocytes

integral
membrane
protein,
mitochondiral
inner
membrane
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alpha-1antiproteinase

AE 1,
CD233
antigen
lipocortin II
hemoglobin
beta chain

type I
membrane
protein
lysosomal
lysosomal

Interphoto-

retinol
dehydrogenase

fatty acid
betaoxidation
Endopeptidase inhibitor
activity
protein
binding
protein
binding
cell ion
homeostasis
calcium ion
binding
oxygen
transport
activity
calcium ion
binding
lysosome

tripeptidylpeptidase I
cytochrome
c oxidase

interstitial

cytochromec oxidase
activity

lipid

receptor retinoidbinding protein

receptor
matrix

retinolbinding
protein

keratinIII

30154839

lysosomal
integral
membrane
protein IIII
myelin protein
zero

1362856

NADHubiquinone
oxidoreductase
Na+/K+exchanging
ATPase

128826

A, B,
D1/2,
E1/2,
F, I, J,
L
E1

88214

D1

peripherin

4506465

A

phospholipase Calpha

303618

F

rhodopsin

4506527

D1/2,
E1/2,
F, G,
H, I

Photoreceptor rod

integral
membrane
protein

rod outer
segment
membrane
protein I
retinal pigment
epitheliumspecific protein
retinal SantigenIII

4506575

A, D2,
H, I

Photoreceptor rod
rim region

integral
membrane
protein

4506591

D2,
E1/2

4506781

F, G

retinal
pigment
epithelium
retina and
pineal gland

Serum albuminI,III

28592

A

plasma

secreted

Transducin

31865

A

trypsinI

Photoreceptor rod

136429

A,
D1/2,
E1/2,
F, G,
H, I,
M

membrane
associated
extracellular

127721

B, F,
M
E1

peripheral
nervous
system
schwann
cells

Photoreceptor rod
rim region
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type II
membrane
protein,
lysosomal
type I
membrane
protein

LIMP II,
CD36
antigen like
2

Mitrochondrial inner
membrane
integral
membrane
protein

NADH
dehydrogenase
sodium
pump 3

integral
membrane
protein
endoplasmic
reticulum

retinal
degeneration
slow protein
protein
disulfide
isomerase
A3
Opsin 2

ROSP1

metabolism,
visual
peception
cytoskeleton
organization
integral to
plasma
membrane
structural
molecule
activity,
synaptic
transmission
electron
carrier
activity
ATP
hydrolysis,
proton
transport
visual
perception
signal
transduction
Phototransduction, Gprotein
coupled
receptor
activity
visual
perception

RPE65

visual
perception

rod photoreceptor
arrestin

signal
transduction
body fluid
osmoregulat
-ion
visual
perception
protease

2D Gel
ATP synthase,
beta subunitII, III

32189394

19,47,
71

calnexinII

2134858

3

calreticulinII, III

4757900

6

calumenin

2809324

16

Creatine
kinase/arginine
kinaseIII, IV
cathepsin DII, III
Ceroidlipofuscinosis,
neuronal 2
dnaK-type
molecular
chaperone
HSPA5
heat shock
protein gp96III

180570

74

mitochondria,
membrane
protein
type I
membrane
protein, ER
endoplasmic
reticulum
lumen
endoplasmic
reticulum
lumen and
secreted
cytoplasmic

494296
5729770

37,38
21,24

lysosomal
lysosomal

87528

4,5,52

endoplasmic
reticulum
lumen

15010550

7

endoplasmic
reticulum
lumen

KIAA0908

4240305

57

ubiquitous

lysosomal

KIAA0617V

40788303

30

motor proteinIII

widely
expressed

516764

74

nuclear and
golgi
mitochondrial
inner
membrane

mutant beta-actin

28336

27

cytoplasmic

NADHubiquinone
oxidoreductase
phospholipase calpha
pre-mRNA
splicing factor
SF2p32
prohibitinII, III

128826
303618

1,2,32,
33,41,
54
11

338043
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Mitrochondrial inner
membrane
endoplasmic
reticulum
mitochondrial
matrix

4505773

39

protein disulfide
isomerase

5031973

7,12,1
9

vimentinII, III

4507895

17

ubiquitously
expressed

widely
expressed

cytoplasmic

tranpsorter
activity
calcium ion
binding
protein
folding
crocalbin

calcium ion
binding
creatine
kinase
activity
lysosome

GRP94,
tumor
rejection
antigen
Prenylcysteine
oxidase
mito. inner
memb.
protein,
mitofilin

NADH
dehydrogenase
hyaluronanbinding
protein 1

response to
unfolded
protein
lysosome,
lyase
activity
cell cycle
arrest
Mitochondrial inner
membrane
Acetyltransferase
complex
electron
carrier
activity
signal
transduction
immune
response
regulation of
cell cycle

endoplasmic
reticulum
lumen
highly

structural
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I
II
III
IV
V

expressed in
constituent
fibroblasts
These proteins were preparation contaminants.
These proteins were identified as components of the macrophage phagosome proteome. [Garin, 2001]
These proteins were reported in Schutt et al. [Schutt, 2002] as LF components.
We were unable to differentiate between these two proteins because of their possessing identical peptide
sequences.
This protein was only identified from one peptide with relatively low confidence.

Discussion
Detecting membrane and microheterogeneous proteins
We report the identification of proteins in retinal lipofuscin (LF) granules.
Because of the lipophilic nature of LF granules and the apparent inability of RPE cells to
degrade them, one would expect to find an abundance of hydrophobic and highly
modified, microheterogeneous proteins in LF granules. Due to the limitations of 2D
electrophoresis, including the lack of solubility of hydrophobic proteins in buffer systems
compatible with 2D electrophoresis and the inability to focus microheterogeneous
proteins into observable spots, 1D electrophoresis was also used to identify proteins in
LF. The previous report [Schutt, 2002] employed only 2D electrophoresis, which limited
the proteins amenable to identification. We have identified 41 total proteins, only five of
which were found in both 1D and 2D gels. Of the 41 proteins that we identified and the
65 nonredundant proteins identified by Schutt et al. [Schutt, 2002], only 12 (11%) were
common to both studies.
An aspect influencing the discrepancy between protein identifications from the two types
of gels is the ability to detect highly hydrophobic proteins, which we expected to be
abundant in LF granules. We found 17 integral membrane and membrane-associated
proteins (about 50% of all LF-specific proteins we identified). The previous report of LF
proteins [Schutt, 2002], which used 2D electrophoresis, found fewer membrane proteins.
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Of the 17 membrane associated proteins that we identified, 13 were found exclusively in
our 1D gel slices, again testifying to the limitations of 2D electrophoresis in analyzing
lipophilic proteins.
Another cause of the inconsistency in proteins identified from 1D and 2D gels
may be from contaminants of LF preparations. Contaminants of LF preparations are
likely to be greatly exacerbated in 2D electrophoresis because they might run as well
focused spots, whereas many of the authentic LF proteins are microheterogeneous and
therefore do not focus on 2D gels (rhodopsin being a notable example, Figure 2-6).
Whenever preparations of subcellular structures are made using centrifugation for
separation based on density, some contamination is inevitable. Indeed, as several others
have noted, such preparations are not truly purifications but are enrichments [Brunet,
2003]. While these are nonetheless valuable preparations, caution should be exercised in
drawing conclusions when analyzing them. We found that we had to load significantly
more material onto the 2D gels than we would have expected for an enriched subcellular
granule. This may have resulted in an overloading of the focusable protein contaminants,
such that they became visible as spots that were subsequently identified (CRALBP as an
example, Figure 2-8). For this reason, we also employed complementary protein
identification from 1D gels. We are aware that the methods we have used do not identify
every protein in the preparations we have studied. Attempting to exhaustively identify all
of the proteins in an enriched preparation such as lipofuscin granules would be
misleading because many contaminating proteins would be identified. Nonetheless, the
proteins we have identified give us a useful, even if somewhat incomplete, view of the
protein constituents of LF.
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We have shown that these granules exhibit the fluorescence characteristics and
microscopic structure previously reported [Boulton, 1990]. We also show that the
granules that we have isolated and characterized physically are biologically active,
causing blue-light-dependent cell death to RPE cells in culture (Figure 2-1), as others
have previously reported [Winkler, 1999]. The only physical characterization of the
granules offered by Schutt et al. [Schutt, 2002] of their LF preparation was fluorescence
spectroscopy. As shown in Figure 2-3, the excitation and particularly the emission spectra
reported by these authors were significantly dissimilar from our fluorescence spectra and
from spectra previously reported in the literature.

Identifying phagosomal, lysosomal, and photoreceptor proteins
Our protein identifications are supportive of the hypothesis that LF has a
lysosomal/phagosomal origin. Four proteins that are lysosomal in subcellular localization
were found in our LF preparations. The proteome of macrophage phagosomes has
recently been published [Garin, 2001], and 10 of the 41 proteins in our LF preparations,
which presumably have a phagosomal origin, are shared with the phagosomal proteome
as reported [Garin, 2001].
The prevailing model of LF origin is that there is a breakdown in the lysosomal
machinery responsible for the degradation of the photoreceptor outer segments that are
phagocytosed diurnally by the RPE, leading to an accumulation of indigestible material
that becomes LF. Our protein identifications strongly support such a model. Six of the LF
proteins that we identified are specific to photoreceptors and their outer segments. Only
one of these was previously reported as a constituent of LF [Schutt, 2002].
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Identifying rhodopsin
One of the most significant proteins that we observed in LF, not observed
previously, is rhodopsin, one of the most abundant proteins of photoreceptor outer
segments. We did not observe rhodopsin among our 2D gel spots. Immunoblotting of our
2D gels showed that this was due to the lack of focusing of the microheterogeneous
rhodopsin population in LF (Figure 2-6). It is significant that the rhodopsin observed is
rather extensively modified, at least in part due to oxidative damage. Though we were not
able to quantify LF rhodopsin precisely, our immunoblot evidence suggests that this
protein is fairly abundant in LF. Although Feeney-Burns et al. [Feeney-Burns, 1988]
were unable to observe rhodopsin in LF granules, we believe that this was due to the
antibody they used. As shown in Figure 2-7 our anti-rhodopsin antibody (R4) specifically
bound to LF granules confirming that the rhodopsin observed is a component of the
granules and not merely a contaminant. The opsin we identified was exclusively
rhodopsin, and no evidence was found that cone opsins were present in LF. It has been
previously noted that the cone-rich fovea is not as high in LF as the rest of the macula
[Sparrow, 2003].

Other specific proteins of interest
Two LF proteins of interest, found in both 1D and 2D gels, are the ceroid
lipofuscinosis protein and cathepsin D. Ceroid lipofuscinosis proteins are found to be
mutated in Batten's disease, a condition in which there is significant accumulation of
lipofuscin in neuronal tissue [Yin, 1996]. The ceroid lipofuscinosis proteins accumulate
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in the lipofuscin granules, along with ATP synthase, other proteins, and lipids [Yin,
1996; Ryan, 1996]. Finding cathepsin D in LF was not surprising. This lysosomal
protease is highly expressed in RPE lysosomes, and is employed by these cells in
degrading rhodopsin [Zimmerman, 1983].
Another protein of interest in these studies is the cellular retinoid binding protein
CRALBP, a protein sometimes used as a molecular marker for RPE cells (but also found
in the Müller cells of the neural retina [Johnson, 1997]). Schutt et al. [Schutt, 2002] found
CRALBP to be one of the most abundant proteins in their preparations (approximately
the fifth most intense spot on the 2D gel, though two proteins were identified from this
spot). In contrast, we find CRALBP to be the 69th most abundant of 121 spots in one gel,
and absent from the other three 2D gels (data not shown). We did not identify CRALBP
from our 1D gels, presumably because it was lost among more abundant proteins. As
seen in Figure 2-8, immunoblotting shows that while CRALBP is present in gels of RLF,
it is not very abundant. It is probable that CRALBP is a contaminant of these
preparations.

Detecting protein modifications
A notable observation from this work is the nature and extent of modifications
seen in LF proteins. Derivatization using DNPH followed by immunoblot analyses with
the anti-DNP antibody shows the presence of abundant protein carbonyl groups in LF,
indicating extensive oxidative damage to proteins. While protein carbonyls are diagnostic
of oxidative damage to proteins [Shacter, 2000, Berlett, 1997], they are certainly not the
only covalent modification that occurs to proteins as a result of such damage. Neither
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Met-sulfoxide nor Met-sulfone are derivatized with DNPH. A notable modification to
proteins under oxidative stress is their fragmentation into smaller polypeptides by the
breakage of backbone bonds [Berlett, 1997]. Such damage would result in peptides upon
trypsinization that have amino or carboxy termini that would not be predicted from the
sequence databases, and may be further modified in terms of covalent structure.
Additionally, covalent modifications of proteins due to oxidative damage are not yet
completely understood, and many unknown modifications could be present, further
complicating the proteomic analyses of the in-gel digest mass spectrometry data. Indeed,
we observed a remarkably high fraction (about 75%) of our "good" CID spectra (criteria
given in Results) that did not yield peptide identification, possibly because many of the
peptides in question are modified in unknown ways. The only modification that we were
able to identify precisely was oxidation of two methionine residues on rhodopsin,
including the formation of the sulfone and the sulfoxide (Figure 2-5A). Ryan et al. [Ryan,
1996] showed oxidation of methionine in ceroid lipofuscinosis protein in lipofuscin of
neural tissue. We mention their findings, because we find the parallel between LF and
neural lipofuscin suggestive. We find that both the ceroid lipofuscinosis protein itself and
methionine oxidation are found in LF. Though we believe that there are significant
differences between retinal LF and LF in other tissues such as neurons; we also believe
that they are not wholly dissimilar. The facts that methionine oxidation is seen in both
types of lipofuscin, and ceroid lipofuscinosis protein (a lysosomal component) occurs in
both types suggests to us that oxidative protein damage inhibiting lysosomal function
may be a shared characteristic (or even causal factor) in the two types of lipofuscin.
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A previous report on LF proteins [Schutt, 2002] was followed up with an article showing
immunological analyses of LF proteins modified by hydroxynonenol (HNE),
malonyldialdehyde (MDA), and advanced glycation end-products (AGE) [Schutt, 2003].
Many of these modifications would be derivatized by DNPH, and thus would be part of
the modified proteins that we observed in Figure 2-7A. For example, HNE has been
shown to react with proteins resulting in a loss of sulfhydryls and a concomitant increase
in DNPH reactivity [Esterbauer, 1991]. In addition, 22% of the MDA incorporated into
polylysine became amino-propenal, which has a DNPH-reactive aldehyde moiety
[Esterbauer, 1991]. Furthermore, one of the two aldehydes in MDA can react with a
protein yielding the imine and possibly leave the other aldehyde to react with the
hydrazine. Glycation, through a Maillard reaction, creates Amadori products that have
free carbonyl groups [Yin, 1996]. The previous report [Schutt, 2003] identified 32 2D gel
spots that react with an anti-MDA antibody, 15 spots that react with an anti-HNE
antibody, and four spots that react with an anti-AGE antibody. Notably, all of these are
well-focused spots, as opposed to the heterogeneously modified proteins we observed
with DNP derivatization (Figure 2-9A). We observed that an anti-MDA antibody reacted
with only a handful of LF proteins (Figure 2-9B), and that an anti-AGE antibody reacted
weakly with a heterogeneous smear of proteins from LF (data not shown). Thus, it is
eminently possible that the general oxidative damage that we describe might well include
specific modifications such as those resulting from MDA, HNE, and AGE. Our specific
efforts to duplicate the findings of Schutt et al. [Schutt, 2003] using our LF preparations
yielded different findings, suggesting the need for further study of the roles of these
specific modifications in the biochemistry of LF.
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Much has yet to be learned about the modifications of proteins in LF granules.
Perhaps it is the oxidative modification of proteins (and possibly of lipids as well) that
inhibits the degradative machinery of the RPE lysosomes, and leads to the accumulation
of LF within these cells. Protease inhibition causes lipofuscin formation in myocytes
[Brunk, 2002]. Oxidative stress causes accelerated lipofuscinogenesis in various cells,
and there is a dramatic synergy between oxidative stress and inhibition of lysosomal
proteases (allowing more time for oxidation) in lipofuscin formation in cultured cells
[Brunk, 2002]. Nilsson et al. [Nilsson, 2003] found greatly enhanced accumulation of LF
in RPE cells cultured in 40% ambient oxygen when compared with cells cultured in 8%
ambient oxygen. We are pursuing experiments aimed at understanding the possible role
of oxidative damage of proteins in lipofuscinogenesis and other aspects of LF origins and
activities.
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CHAPTER 3
MELANOLIPOFUSCIN ORIGIN & COMPOSITION

Summary
Melanolipofuscin (MLF) is a complex granule, exhibiting properties of both
melanosomes and lipofuscin (LF) granules. MLF accumulates in retinal pigment
epithelial (RPE) cells and may contribute to the etiology of age-related macular
degeneration (AMD). MLF accumulation has been reported by Feeney-Burns to more
closely reflect the onset of AMD than the accumulation of lipofuscin. In an effort to
assess the possible contribution MLF may have to the onset of AMD, we analyzed the
phototoxicity and protein composition of MLF and compared those results to that of LF.
Specifically, we observed the accumulation of MLF in human RPE from different
decades of life, and assessed the phototoxicity of these granules. We also employed
fluorescence spectroscopy, atomic force microscopy, transmission and scanning electron
microscopy and proteomic analysis to examine the composition of MLF granules in an
effort to ascertain their origin. Our results show that MLF granules are phototoxic and
their accumulation more closely reflects the onset of AMD than does LF accumulation.
Our compositional analysis of MLF has shown that while these granules contain some
similarities to LF granules, MLF is substantially different. Of significant interest is the
finding that MLF, in contrast to LF, does not contain photoreceptor-specific proteins,
suggesting that MLF may not originate from the phagocytosis of photoreceptor outer
segments. Instead the presence of RPE- and melanosome-specific proteins would suggest
that MLF accumulates as a result of the melanosomal autophagocytosis of RPE cells.
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Our results provide significant insight into understanding the formation and toxicity of
MLF and support its role in the etiology of retinal disease.

Introduction
Several retinal diseases, including age-related macular degeneration (AMD), have
been associated with the accumulation of autofluorescent granules in retinal pigment
epithelial (RPE) cells. One such autofluorescent granule, lipofuscin (LF), may relate to
the onset of these ocular diseases because it has been shown to generate reactive oxygen
species via photosensitization with blue light [Beatty, 2000; Winkler, 1999; Wassell,
1999; Rozanowska, 1995]; which may cause damage and death of the RPE with
subsequent death of the surrounding cells. However, as Feeney-Burns has reported
[Feeney-Burns, 1984], the accumulation of LF in human RPEs is not consistent with the
onset of AMD. The most dramatic increase of LF in human RPEs, a 95% increase,
occurs between young and middle-aged groups (defined as ages 1-20 and 21-60
respectively) while there is only a 21% increase between middle-aged and old-aged
groups (ages 61-100) [Feeney-Burns, 1984]. The presence of significant quantities of LF
in young eyes may cast doubt on its contribution to the etiology of AMD.
Another autofluorescent granule that accumulates in RPE cells and may
contribute to the etiology of AMD is a complex granule exhibiting properties of both
melanosomes and lipofuscin granules called melanolipofuscin (MLF). In contrast with
the accumulation of LF in the RPE, MLF accumulation has been reported by FeeneyBurns to more closely reflect the onset of AMD. MLF exhibits a 15% increase between
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young and middle aged groups and a 50% increase between middle-aged and old-aged
groups {Feeney-Burns, 1984].
MLF may contribute to the etiology of AMD, but little is known about the
composition and origin of these complex granules. Two models for the origin of MLF
have been suggested. The first model involves the autophagy of preexisting melansomes
and their incorporation into accreting LF granules. This model is supported by the
observation that phagosomes containing undegradable material fuse with melanosomes
[Schraermeyer, 1999]. The second model is that melanin is synthesized de novo in
lysosomes, which subsequently fuse with accreting LF granules. This model is supported
by evidence that synthesis of melanin in depigmented RPE cells is seen in lysosomal
compartments [Dorey, 1990; Schraermeyer, 1994]. Knowledge of the composition of
MLF could provide significant insight into the origin of these granules, and determining
the phototoxicity of these granules could be useful for ascertaining MLF’s role in the
etiology of AMD and other retinal diseases.
In the present study we observed the accumulation of MLF in human RPE from
different decades of life and assessed the phototoxicity of these granules. We also
employed fluorescence spectroscopy, atomic force microscopy, transmission and
scanning electron microscopy and proteomic analysis – using 1D gel electrophoresis
coupled with ESI mass spectrometry – to examine the composition of MLF granules in an
effort to ascertain their origin. Collectively these data provide significant insight into
understanding the formation and toxicity of MLF and support its role in the etiology of
retinal diseases. Specifically, these data do not provide direct support for either
previously suggested hypothesis for the origin of MLF, but instead suggest that MLF
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accumulates as a result of the melanosomal autophagocytosis of RPE cells. To our
knowledge this is the first report of the phototoxicity and biochemical analysis of retinal
melanolipofuscin.

Materials and Methods

Lipofuscin and Melanolipofuscin Isolation and Fluorescence - Lipofuscin granules were
isolated as previously described [Warburton, 2005] and MLF granules were isolated from
these preparations. Briefly, granules were isolated from human RPE from donor eyes,
provided by Dr. Paul Bernstein of the Moran Eye Institute, University of Utah, Salt Lake
City, UT. The time between donor death and enucleation was 1-4 hours, after which the
donor eyes were stored at 4ºC until dissection. Dissections were carried out 6-24 hrs
after donor death in a dim light environment. RPE’s were stored at -75°C until use.
Lipofuscin granules were isolated from the band at the 0.3M/1.0M interface and
melanolipofuscin granules were isolated from the bands at the 1.0M/1.2M and
1.2M/1.4M interface. Sucrose gradients were only briefly exposed to light while
photographs of the gradients were taken. Fluorescence spectra of isolated lipofuscin and
melanolipofuscin granules were acquired as described by Boulton et al. [Boulton, 1990]
using a Jobin Yvon Fluoromax-3 Spectrofluorometer (Edison, NJ).

LF and MLF Accumulation - To study the accumulation of LF and MLF over time,
sucrose gradient centrifugation was employed using four groups of RPE, each consisting
of 6 RPE and representing a different decade of life. The first group had an average age
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of 33 ± 1.6 yrs; the second group had an average age of 43 ± 0.9 yrs; the third group had
an average age of 54.3 ± 1.9 yrs; and the fourth group had an average age of 64 ± 0.0 yrs.
To compare the LF and MLF content in young and old eyes, sucrose gradients were run
with 11 RPE from young eyes (average age of 21.2 ± 5.9 yrs) and 14 RPE from old eyes
(average age of 66.5 ± 5.9 yrs). Pictures of the gradients were taken using an Olympus
Camedia digital camera. Image J (National Institutes of Health) was used to measure the
optical density of LF and MLF bands in the sucrose gradients.
All other experiments were performed using LF and MLF isolated from RPE’s taken
from a random donor population between 40 and 80 years old.

Cell Culture - ARPE-19 (human retinal pigment epithelial cells – ATCC-CRL-2302)
were grown in 24-well tissue culture plates in RPMI 1640 media supplemented with 10%
fetal bovine serum (FBS). Upon reaching confluency the FBS in the media was reduced
to 1%. Cells were either maintained in RPMI 1640 media supplemented with 1% FBS or
incubated in the same media which also contained ~300 melanolipofuscin or lipofuscin
granules/cell for 24 hours to allow for ingestion of the granules. After the 24 hour
incubation, the melanolipofuscin- or lipofuscin-fed RPE cells were transferred back to
RPMI 1640 media supplemented with 1% FBS and maintained for 3 days before
bioactivity assay.

Bioactivity Assay - To investigate the bioactivity of MLF, ARPE-19 cells that were fed
LF, MLF or neither (control cells) were either subjected to blue light (390-550 nm) for 48
hr at an intensity of ~2.8 mW/cm or maintained in the dark. Blue light was introduced
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into a 5% CO2 humidified cell incubator using a Mille Luce M1000 Fiber Optic
Illuminator with a 150 W quartz halogen bulb, a 25-mm dichroic blue light filter, and a
48 inch fiber optic cable which obviates heat (Edmund Optics, Barrington, NJ).
Photocytotoxicity of the lipofuscin and melanolipofuscin granules was assessed using
Sulforhodamine B (JNCI 82, p1107 (1990)) to measure cell viability. Briefly, cultures
were fixed with trichloroacetic acid and stained with 0.4% sulforhodamine B in 1% acetic
acid. The cultures were washed 4 times with 1% acetic acid to remove any unbound dye;
protein-bound dye was extracted with 10 mM unbuffered Tris base and transferred to a
96 well culture plate. Absorbance was measured at 570 nm on a CERES UV900 HDi
plate reading spectrophotometer (Bio-Tek Instruments).

Microscopy - MLF granules were prepared for scanning electron microscopy (SEM)
analysis by drying the granules on a silicon wafer and sputter coating them with gold.
The granules were analyzed on a Phillips XL30 ESEM FEG using a 5kV accelerating
potential. For transmission electron microscopy (TEM) analysis MLF granules were
fixed in glutaraldehyde, postfixed in osmic acid, dehydrated and embedded in epoxy
resin. 100 nm slices of the sample were imaged and photographed on a JOEL JEM 2000
FX.
MLF samples for atomic force microscopy (AFM) were prepared by drying the granules
onto a mica slide. Images were taken with a Multimode IIIa AFM instrument with
microfabricated Si cantilever tips (Nanoscience Instruments, Phoenix, AZ). Vibrational
noise was dampened using an active isolation system (MOD1-M, Halcyonics,
Goettingen, Germany). Typical imaging parameters were (a) tip resonance frequency,
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55-65 kHz; (b) amplitude setpoint, 2.0-2.5 V; (c) scan rate, 2.0 Hz. Images were
processed offline to remove the background slope using software bundled with the AFM
instrument.

Flow Cytometric Analysis - To determine the size distribution and concentration
(granules/unit volume), suspensions of MLF granules were diluted 1:100 and 1:1000 with
PBS and 200,000 Flow Check High Intensity Green Alignment Beads (Polysciences,
Inc., Warrington, PA), 5.726 ± 0.375 μm in diameter, were added to each sample to serve
as an internal standard. The samples were excited with an argon laser at 488 nm on a
Beckman Coulter (Beckman, Fullerton, CA) EPICS-XL Flow Cytometer with EXPO 32
ADC software for flow cytometric analysis. The samples were analyzed for forward light
scatter and autofluorescence by collection of data for 300 sec, which allowed
visualization of at least 10,000 beads and at least 95,000 MLF granules.

Total Protein Determination in Melanolipofuscin - Melanolipofuscin granules were
pelleted using centrifugation and lyophilized in an evaporative centrifugal concentrator.
The granules were weighed using a Mettler UMT2 microbalance (Columbus, OH) to
determine their total mass. After weighing the dried granules, the protein in these
melanolipofuscin samples was quantified by solubilizing the granules in 1% SDS
followed by the BCA Protein Assay (Pierce, Rockford, IL). Three independent
measurements were used to calculate the percent protein and standard deviation.
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1D Gel Electrophoresis and Mass Spectrometry - Melanlolipofuscin and lipofuscin
granules containing 100 μg of protein were pelleted by centrifugation, solubilized in 4X
Laemmli buffer (3% SDS, 0.17 M Tris pH 6.8, 35% glycerol, 3.5% 2-mercaptoethanol)
and separated on a 10% SDS-PAGE gel (8.3 x 6.4 x 0.1 cm). The gel lanes were sliced
into sections and the proteins were digested in-gel as described by Shevchenko et
al.[Shevchenko, 1996], injected onto a Jupiter C18 reversed-phase resin capillary column
(150 μm ID, made in-house), and eluted using a gradient of 5 to 95% acetonitrile in 0.1%
formic acid at a flow rate of 5 μl/min. On-line mass spectrometric analysis was
performed on an Applied Biosystems QSTAR Pulsar i (Foster City, CA) using an API
(atmospheric pressure ionization) source. Automated tandem mass spectrometry using
information-dependent acquisition was run, collecting CID spectra for the three most
intense ions from each survey scan excluding peaks chosen in the preceding 2 min.
Fragmentation spectra were submitted to the Mascot (Matrix Science) website
(www.matrixscience.com) for peptide identification. Proteins in MLF granules from
three independent preparations were examined. Each 1D gel lane containing MLF or LF
proteins was cut into 24 gel slices for mass spectrometric analysis. Four gel slices
(numbers 15, 16, 17, and 19) from two preps of LF granules were selected for analysis to
provide a direct comparison of the differences in LF and MLF proteins. Relative
quantitation of proteins was estimated using the method of spectral counting [Old, 2005].

Immunoblots - Human retinas were obtained from Dr. Paul Bernstein from the Moran
Eye Institute to make a positive control for rhodopsin. A retina was gently triturated in
0.75 M sucrose, 0.68 mM calcium chloride, 20 mM tris and 1 mM DTT pH 7.4 to rupture
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the cells. The suspension was poured over 4 thicknesses of cheesecloth to remove debris.
The sample was spun at 1475 x g for 20 min and the pellet was resuspended in 1% SDS.
Total protein was determined using the BCA assay. An α-rhodopsin antibody (R4,
polyclonal antibody, see Takemoto et al.[Takemoto, 1985]) was used at 1:1000 dilution
in TBS-T.
Oxidized BSA samples were made by incubating BSA in hypochlorous acid at 37°C for
30 minutes. LF, MLF and BSA samples were derivatized by incubating them in 5%
sodium dodecyl sulfate and 10 mM 2,4-dinitrophenylhydrazine(DNPH) in 10% (v/v)
trifluoroacetic acid for 30 minutes at room temperature. The solutions were neutralized
by adding 2M Tris and Laemmli buffer (3% SDS, 0.17 M Tris pH 6.8, 35% glycerol,
3.5% 2-mercaptoethanol) and loaded directly onto a gel. Anti-DNP antibody from rabbit
was purchased from Sigma.

Results
Side by side comparison of the LF and MLF content in RPE from young (21.2 ±
5.9 yr) and old (66.5 ± 5.9 yr) individuals as seen in sucrose gradients is shown in Figure
3-1A. This figure confirms the presence of significant quantities of LF in RPEs from
young individuals where very little if any MLF is present. In contrast RPEs from older
individuals show significant quantities of MLF. This accumulation pattern is further
evident when the optical density of the MLF and LF bands in sucrose density gradients is
plotted versus the age of the RPE donor. (Figure 3-1B)
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Figure 3-1. Melanolipofuscin (MLF) Accumulation. A) Comparison of MLF granules from
RPE of young (21.2 ± 5.9 yrs) and old (66.5 ± 5.9 yrs) human donors. B) Age of RPE donor
versus optical density of MLF/LF plotted to show the accumulation of MLF throughout life.
LF granules are observed in human RPE from young individuals, whereas significant
quantities of MLF do not appear to accumulate for decades afterward.

Analysis of the phototoxicity of MLF revealed that these granules cause a 58%
decrease in cell viability in ARPE-19 cells fed with MLF and exposed to blue light for 48
hours. This is compared to an 80% decrease in cell viability in ARPE-19 cells fed with
the same number of granules of LF (Figure 3-2). Although this colorimetric assay
provides an informative approximation of the phototoxicity of these granules, we are
aware that the nature of ARPE-19 cells makes it difficult to precisely determine the
phototoxicity of these granules. ARPE-19 cells migrate up the sides of tissue culture
plates as they proliferate and phagocytose far fewer granules in this sideways position.
These cells depress phototoxicity results because their inability to phagocytose granules
inhibits them from undergoing light dependent cell death. Thus, these phototoxicity
measurements are overly conservative. However, the relative comparison of LF & MLF
phototoxicity is not affected.
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Figure 3-2. Bioactivity of LF & MLF Granules. Isolated LF & MLF granules were fed to
ARPE-19 cells. Cells that were not fed LF or MLF were used as controls. Cells were then
subjected to blue light irradiation (solid bars), or left in the dark (cross-hatched), for 48
hours. Cell viability was determined using the Sulforhodamine B assay. Values represent
mean of at least four independent measurements, error bars represent standard deviation.
The phototoxicity of MLF granules in ARPE-19 cells is at least 72% as potent as that of LF
granules, showing that MLF granules have the potential for deleterious affects on RPE cells
in the retina.

Several physical measurements of MLF granules were made using fluorescence
spectroscopy, electron microscopy, atomic force microscopy, and flow cytometry.
Fluorescence of MLF and LF granules is shown in Figure 3-3. Both granules
produce similar excitation spectra (data not shown), however, MLF granules have an
emission maximum at 554 nm, whereas LF granules have an emission maximum at 578
nm. The similarity between the fluorescence spectra of these two granules is expected
because of the A2E fluorophore present in both granules which dominates the spectra
[Vollmer-Snarr, 2004]. Apparently, melanin in MLF produces significantly less emission
and appears to be negligible in comparison to the fluorescence of A2E (data not shown).
The shoulder at ~470nm in the fluorescence spectrum of MLF increased over time when
exposed to light eventually becoming the maximum in the spectrum (data not shown).
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This change may result from the accumulation of damage on the proteins within MLF
granules as a result of light exposure or from photo-isomerization of A2E or other lipids.
This trend was also observed with LF (data not shown).
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Figure 3-3. Fluorescence
Emission Spectra of LF &
MLF. Fluorescence emission of
LF & MLF monitored with
excitation at 364 nm. Both
granules produce similar
excitation spectra (data not
shown), however, MLF
granules have an emission
maximum at 554 nm, whereas
LF granules have an emission
maximum at 578 nm.
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SEM and AFM analyses of MLF granules (Figure 3-4A-C) show nearly spherical
granules with some surface features which suggest these granules are aggregates of
smaller substructures. Transmission electron micrographs of MLF (Figure 3-4D) show
these granules to contain inclusions of higher density, demonstrating that these granules
are complex and not a mixed population of different granules.
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A

B

C
Figure 3-4. Microscopic Structure of
MLF. A) Scanning electron micrograph of
MLF, showing nearly spherical granules
with some surface features. B,C) Atomic
force micrographs (phase images) showing
MLF granules to be aggregates of ~200 nm
and ~50 nm substructures. D)
Transmission electron micrograph of MLF,
shows these granules to contain inclusions
of higher density, demonstrating that these
granules are complexes of lipofuscin and
melanin. Each bar represents 0.5 um.
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Flow cytometric (FC) analysis allowed a quantitative determination of granule
size. Forward light scatter in FC instruments is directly proportional to the size of the
objects passing through the beam. The MLF granules were found to have a mean
diameter of 0.93 μm and a broad standard deviation of 0.60 μm. Flow cytometry also
enabled a quantitative determination of the concentration of granules in our suspensions.
Having a count of the MLF granules, we were able to determine their average weight,
which proved to be 2.2 ± 0.1 pg /granule. When compared to LF, MLF is ~35% larger
but weighs ~69% more, again indicating the presence of a more dense substance.
LF

118 kDa
86 kDa
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34 kDa
26 kDa
19 kDa

MLF
1
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Figure 3-5. Electrophoresis of LF & MLF
Proteins. Representative SDS-PAGE lanes of
50 μg of LF and MLF proteins. Mobility of
molecular weight markers are indicated to the
left. On the right, gel slices taken for
subsequent in-gel digestion are shown. The
lack of well-focused bands in the gel lane
indicates microheterogeneous populations of
the proteins, probably resulting from extensive
modifications.
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To determine the percent protein composing MLF granules, the protein in a
known quantity of MLF was solubilized in 1% SDS and quantified by BCA assay. MLF
proved to consist of 60.7 ± 6.4% total protein. Compared to LF, MLF contains more
protein and therefore less extractable lipids [Warburton, 2005].
Table 3-2. MLF proteome comparison with other organelles. The proteome of MLF was
compared to the proteome of several relevant organelles. Organelles are listed in order of
decreasing number of proteins in common with MLF.
organelle
melanolipofuscin
RPE melanosomes
phagosomes
lipofuscin
melanocyte melanosomes

total
proteins
110
102
140
36
68

no. of
common
–
23
18
14
7

percent

reference

–
22.5
12.9
38.9
10.3

this study
Azarian et al.
Garin et al.
Warburton et al.
Basrur et al.

Because of the possibility that the proteins in MLF granules are highly modified
exhibiting highly heterogeneous populations and therefore unfocusable on 2D gels, we
employed 1D SDS-PAGE coupled with automated LCMSMS to identify the protein
constituents of MLF. Figure 3-5 shows representative 1D lanes of LF and MLF proteins
and indicates the gel slices removed from the lanes. Proteomic analyses of the proteins in
the 1D gel slices identified 110 proteins in MLF granules which are listed in Table 3-1
(found at the end of the results section in this chapter). The proteome of MLF granules
was compared to the proteome of other relevant organelles including RPE melanosomes,
macrophage phagosomes, retinal LF, and melanocyte melanosomes. As indicated in
Table 3-2, 23 proteins were previously identified in mature RPE melanosomes [Azarian,
2006], 18 proteins were previously identified as part of the macrophage phagosome
proteome [Garin, 2001], 14 proteins were previously identified in LF granules
[Warburton, 2005], and 7 proteins were identified in melanocyte melanosomes [Basrur,
2003].
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Figure 3-6. Semi-quantitative analysis of photoreceptor- and RPE-specific proteins in LF
and MLF granules. Spectral counting was performed on two photoreceptor-specific
proteins, rhodopsin and peripherin, and two RPE-specific proteins, RGR and rpe65, in 4 gel
slices from LF & MLF 1D gels. Photoreceptor-specific proteins were only identified in LF
granules, while RPE-specific proteins were mainly identified in MLF granules. Although
RGR was identified in LF granules it appeared to be ~58% less abundant than in MLF
granules. This supports the hypothesis that LF granules originate from photoreceptors while
MLF granules appear to originate from autophagy of RPE cells.

Four gel slices from MLF and LF 1D gels were analyzed for a direct semiquantitative comparison of RPE- and photoreceptor-specific proteins in these granules.
Spectral counting of two photoreceptor-specific proteins, rhodopsin and peripherin, and
two RPE-specific proteins, RGR and rpe65, from these four gel slices is show in Figure
3-6. The two photoreceptor-specific proteins were identified in LF granules but absent
from MLF granules while RPE-specific proteins were more abundant in MLF granules.
Although RGR was identified in LF granules, it appears to be ~58% less abundant than in
MLF granules. A more comprehensive study of the proteins in LF granules was
previously published by Warburton et al.[Warburton, 2005].
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RHO LF
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MLF
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Figure 3-7. Rhodopsin Immunoblot.
Immunoblot following SDS-PAGE of 1 and
3 μg of total LF protein and 10 and 50 μg of
total MLF protein. Shown for comparison is
6 μg of protein from photoreceptor cell
membranes enriched from human retina.
Rhodopsin runs on SDS-PAGE as a mixture
of the monomer (~30 kDa), dimer (~60 kDa),
and trimer (~90 kDa). Although rhodopsin is
seen to be present in abundance in LF
granules, no significant quantity of rhodopsin
is detected in MLF granules.

118 kDa
86 kDa

47 kDa

34 kDa

26 kDa

Rhodopsin was previously shown to be abundant in LF granules [Warburton,
2005], however; this protein was only identified in a single gel slice from 1 of the 3 MLF
preparations analyzed. In order to more quantitatively examine this apparent lack of
rhodopsin in MLF granules, we performed an immunoblot of MLF proteins in which we
used an α-RHO antibody to detect rhodopsin. Figure 3-7 shows that indeed no significant
amount of rhodopsin was detected in MLF granules.
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Figure 3-8. DNP Immunoblot. LF and MLF proteins, 1.4 and 4 μg, that had been
derivatized with dinitrophenylhydrazine (DNPH) or not (control) were run on SDSPAGE, transferred to nitrocellulose, and probed with an α-DNP antibody to show
the derivatized protein carbonyls, a common product of protein oxidative damage.
Shown for comparison and to demonstrate specificity are lanes of BSA, BSA
treated with DNPH, and BSA oxidized with hypochlorite then treated with DNPH.
Oxidative damage on proteins in LF and MLF granules is both extensive and
comparable, though not identical.

Because of the extensive modifications on proteins in LF granules that have been
previously reported [Warburton, 200], we used immunoblot techniques to detect
oxidative modifications on proteins in MLF granules. Dinitrophenylhydrazine (DNPH)
was used to derivatize protein carbonyls, a common product of protein oxidation, and
was detected using an α-DNP antibody. Figure 3-8 shows that the degree of oxidative
modifications on proteins in MLF and LF granules is both extensive and comparable,
though not identical.
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Table 3-1. Proteins identified in melanolipofuscin granules. MLF proteins were fractionated on a 1D gel.
The gel lanes were sliced into sections and the proteins were digested and analyzed using automated LCMSMS and then identified using Mascot. Gel number refers to three separate preparations that were
analyzed.
Gel

Protein

Gel Slice

1,2

acid ceramidaseIII

13

1,2,3

actin, betaIII

2

alpha actinin 4II

11,12,13,14,15
,16
6

1

alpha tubulin,
ubiquitous

3
3
1,2,3

alpha tubulin 2
alpha tubulin 4I
alpha tubulin 6III

3

Ankyrin 1IV

1,2,3
2
2,3

3
2,3

1,2,3

2,3

1,2,3

1,2,3

Genbank
Ascession #
3860240

Synonyms
putative heart
protein

Subcellular
location
Lysosomal.

Tissue
Specificity
Widely
expressed

Nuclear and
cytoplasmic

Widely
expressed

Cytoplasmic
surface of
erythrocytic
plasma
membrane.

Erythrocyte

14250401
12025678

1,2,4,5,6,7,9,1
0,13,15,17,18,
19,21
9,10,11,24
10
1,5,10,11,12,1
3,14,18,20,21,
23,24
3,4

105337

Annexin A2I
Annexin A5III
aspartate
aminotransferase

12,13,14,15
15,16
14

18645167
12655149
4504069

ATP Synthase
subunit g
ATP Synthase,
H+ transporting,
mitochondrial F0
complex, subunit
6
ATP Synthase,
H+ transporting,
mitochondrial F0
complex, subunit
b
ATP Synthase,
H+ transporting,
mitochondrial F0
complex, subunit
d
ATP Synthase,
H+ transporting,
mitochondrial F0
complex, subunit
f
ATP Synthase,

24

3659901

22

29690552

18

13543618

22

5453559

23

13277542

2,9,10

30583257

F-actin cross
linking protein

5174477
37492
13376539
13436317
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transaminase A,
Glutamate
oxaloacetate
transaminase-2

Mitochondrial matrix.

Mitochondrial.

1,2,3

2,3

1,2,3

1,2,3
3
1,2,3

H+ transporting,
mitochondrial F1
complex, alpha
subunit
ATP Synthase,
H+ transporting,
mitochondrial F1
complex, beta
subunitII,III
ATP Synthase,
H+ transporting,
mitochondrial F1
complex, gamma
subunit
ATP Synthase,
H+ transporting,
mitochondrial F1
complex, subunit
o
beta tubulinII,III
beta tubulin
polypeptide
calnexinI,II,III

10

32189394

16

16877071

Mitochondrial.

20

54696534

Mitochondrial matrix.

10,11,14,15,23

20809886

10,11,12,13,21

12804971

6

2134858

2,3
1,2

Cathepsin DI,II,III
cell deathregulatory
protein GRIM19

15,16,17
23

30582659
21361822

2,3

Cerebroside
sulfate activator
protein
CeroidlipofuscinosisI,II

23

337760

12,13

15928808

19,21

37183236

24

37590612

2,3

1,2,3
3

chromosome 10
open reading
frame 58
chromosome 10
open reading

64

Widely
expressed

Ubiquitously
expressed
MHC I antigen
binding protein
p88

NADHubiquinone
oxidoreductase
B16.6 subunit,
Gene associated
with retinoicinterferoninduced
mortality 19
protein

tripeptidylpeptidase I
precursor,
lysosomal
pepstatin
insensitive
protease
SFLQ611

Type I
membrane
protein.
Endoplasmic
reticulum.
Lysosomal.
Mitochondrial inner
membrane

Lysosomal.

Widely
expressed

All tissue

3
3
2,3
2,3

2
1

frame 70
chromosome 20
open reading
frame 3
chromosome 8
open reading
frame 2
crystallin, alpha
BII
cytochrome c
oxidase subunit
III

cytochrome c
oxidase subunit
IV
cytokeratin 9IV

12

37183270

13

37181322

22

30582379

22

14016

23

54696512

1

435476

Type II
membrane
protein
Membraneassociated
heat shock
protein B5

Epidermal
cytokeratin 2IV

1

181402

2

erythryocyte
membrane
protein band
4.2IV
Gammaglutamyltransferase-like activity 1
glucose regulated
proteinIII

7,8

4557559

10,11

4758432

7

6900104

1

gp25L2

19

996057

2,3

Guanine
nucleotide
binding protein
Guaninenucleotide
binding protein,
alpha transducin
heat shock 70 kD
protein 9BIII

16

386750

G(o) alpha
subunit I

13

22027522

G protein

8,9

21040386

mortalin-2

2
2

1

1,2
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Lens as well as
other tissues.
Integral
membrane
protein.
Mitochondrial inner
membrane.
Mitochondri
al inner
membrane.

1

dnaK-type
molecular
chaperone, BiP
protein, hsp A5

Ubiquitous

Membraneassociated
and
cytoplasmic
Type II
membrane
protein
Endoplasmic
reticulum
lumen.
Type I
membrane
protein.
Endoplasmic
reticulum

Ubiquitous
Terminal
differentiated
epidermis of
palms and
soles
Epidermal
tissue,
squamous
metaplasias
and
carcinomas
Erythrocyte

1

heat shock
protein 27

18,19

662841

estrogenregulated
protein, stress
responsive
protein

2

heat shock
protein 60III

10

306890

2,3

heat shock
protein gp96

6

15010550

chaperonin 60,
mitochondrial
matrix protein
tumor rejection
antigen, 94kD
glucose
regulated protein

1,2,3

hemoglobin beta
chainIV
hemoglobin,
alpha 2IV
hemoglobin,
beta, mutantIV
hydroxyacyl
dehydrogenase,
subunit A

23

4378804

24

22671717

24

4837723

8

20127408

hydroxyacyl
dehydrogenase,
subunit B
hypothetical
protein
MGC5508
keratin 1IV
keratin 10IV
keratin 2aIV
keratin 6BIV

12

4504327

20,21

13129092

11
16
6
1

17318569
71528
47132620
21961227

Microsomal
epoxide
hydrolase 1II
microsomal
glutathione Stransferase 3

12

537526

23

34732734

2

motor protein

6,7

516764

2

myelin protein
zeroI
myosin heavy
chain 11II
Myosin heavy
chain nonmuscle

15,19

469517

2

13124879

2,4

41406064

3
3
2

2,3
1,2,3
1,2,3
2,3
2
1

2,3
2

2,3
2,3
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Mitotic
spindles in
mitotic cells;
nucleus
during heat
shock.
Mitochondrial matrix.
Endoplasmic
reticulum
lumen.
Red blood
cells
Red blood
cells

Long chain 3hydroxyacylCoA
dehydrogenase

inner memberane
protein,
mitochondrial;
mitofilin,
KIAA0866

Mitochondrial.

Membranebound on
microsomes.
Integral
membrane
protein.
Microsomal
Mitochondrial inner
membrane.

Epithelial in
oral mucosa,
esophagus,
papillae of
tongue & hair
follicle
Liver
Widely
expressed

2,3
3
1,2,3

10II
Myosin heavy
chain nonmuscle
form AIII
myosin light
chain 3
Na+/K+ ATPase
alpha chainI,II

2

625305

24

188590

4,5,6

88214

MYH9

2

NAD(P)
transhydrogenase

5

1000704
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These proteins were previously identified as components of lipofuscin granules.
These proteins were previously identified as part of the melanosome proteome.
III
These proteins were previously identified as part of the macrophage phagosome proteome.
IV
These proteins are preparation contaminants.
II

Discussion
MLF accumulation
Sucrose density gradients of human RPE from different decades of life illustrated
that MLF is virtually non-existent in the RPE of younger individuals even though LF
granules appear to be abundant in these RPE and has been detected in RPE as young as
18 years of age (data not shown). Consistent with Feeney-Burns’ results [Feeney-Burns,
1984], MLF does not begin to accumulate significantly until midlife. This accumulation
of MLF later in life is consistent with the onset of AMD which affects 2% of individuals
over 50 and 30% of individuals over 75 [Group, 1993]. This correlation would suggest
that MLF may play a more significant role in the etiology of AMD.

Bioactivity
Of significant interest is the fact the MLF is biologically active, showing a lightdependent decrease in cell viability in ARPE-19 cells fed MLF and placed in blue light
for 48 hours. To our knowledge this is the first report of the phototoxicity of MLF. The
phototoxicity of MLF granules in ARPE-19 cells is at least 72% as potent as that of LF
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granules. These data show that MLF granules have the potential for deleterious affects
on RPE cells in the retina.

Protein composition and modifications
The physical characteristics of MLF granules support the description of MLF as a
complex granule with characteristics of both melanosomes and LF. The most compelling
characteristic of MLF is the protein complement identified in the granules. Of the 110
proteins identified as components of MLF, 23 were previously identified in mature RPE
melanosomes [Azarian, 2006], 18 were previously identified as part of the macrophage
phagosome proteome [Garin, 2001], 14 were previously identified in LF granules
[Warburton, 2005], and 7 were identified in melanocyte melanosomes [Basrur, 2003]. As
expected, MLF granules appear to be considerably more similar to RPE melanosomes
than to melanocyte melanosomes. While LF and MLF granules contain a significant
number of similar proteins, these proteins appear to be related to the lysosomal processes
which these granules both participate in. However, the lack of similar cell specific
proteins would suggest different origins of the material being degraded.
Of interest is the presence of RPE65, which we previously identified in LF
granules where it appeared to be far less abundant than we observe in MLF granules.
RPE65 was previously identified in 3 of 15 gel slices from a 1D lane of LF proteins and
in 12 of 24 gel slices from a 1D lane of MLF proteins. RPE65 plays a key role in the
isomerization of retinol as part of the visual cycle in the RPE and is therefore crucial to
proper visual acuity. In contrast to RPE65, rhodopsin – which is abundant in LF – is
practically absent from MLF.
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Of significant interest is the finding that MLF, in contrast to LF, does not contain
photoreceptor-specific proteins, suggesting that MLF does not originate from the
phagocytosis of photoreceptor outer segments. Instead, the presence of RPE- and
melanosome-specific proteins would suggest that MLF accumulates as a result of the
melanosomal autophagocytosis of RPE cells. Our results appear to support neither of the
two previously proposed hypotheses for the origin of MLF (see introduction) and instead
suggest a new hypothesis for its origin. This new hypothesis for the formation of MLF
granules is also supported by recent evidence that melanosomes function as specialized
lysosomes. Evidence for this specialized function includes the related biogenesis of
melanosomes and lysosomes [Orlow, 1995; Raposo, 2002], the observed fusion between
phagosomes and melanosomes [Schraermeyer, 1999], and the presence of lysosomal
enzymes in melanosomes [Azarian, 2006].
The proteins in MLF granules were shown to be extensively modified by
oxidative damage. The degree of oxidative damage is comparable to that found on LF
proteins. The prevalence of oxidative damage on these proteins may render them
undegradable by the cell and therefore lead to their accumulation in MLF granules.
Collectively these data provide significant insight into understanding the
formation and toxicity of retinal MLF and suggest a new theory for its formation as well
as support its role in the etiology of retinal diseases. Our findings suggest that MLF
might result from the accumulation of undegradable material—perhaps undegradable due
to oxidative damage—in the autophagocytic melanosomes of RPE cells. Furthermore,
MLF granules might pose serious risk of photosensitization of these cells allowing blue
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light to produce cell death by liberation of reactive oxygen species, perhaps contributing
to AMD.
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CHAPTER 4
A NOVEL METHOD FOR THE DETECTION AND ENRICHMENT OF OXIDIZED
PROTEINS

Summary
Protein oxidation has been implicated in the development of various pathologies
including ischemia/reperfusion, aging, cataract formation, etc. Although protein
oxidation has been associated with numerous human diseases, a definitive casual role of
protein oxidation in many diseases is still lacking. Because of its wide applicability to
disease states, protein oxidation has become the subject of extensive research. However,
because of the high heterogeneity and low stoichiometry of these post translational
modifications, studying protein oxidation has been a formidable challenge to researchers.
One major problem that impedes research of oxidized proteins involves the difficulty of
isolating and identifying the oxidized proteins and their modified peptides. It therefore
becomes requisite to develop more efficient techniques for the analysis of oxidatively
damaged proteins. The development of new methods for the analysis of protein oxidation
may help establish definitive ties between certain pathologies and oxidative
modifications. To this end we have developed a novel method for the isolation and
identification of oxidized proteins using an Oxidized Protein Affinity Tag (OPAT).
OPAT employs a hydrazine moiety to derivatize oxidized proteins, thereby acting as an
identifier of oxidative damage. In addition, OPAT has been conjugated to biotin,
facilitating isolation of oxidized proteins through a biotin/avidin interaction. We herein
report a comparison of 2,4-dinitrophenylhydrazine (DNPH) and OPAT in the detection of
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protein oxidation as well as demonstrate OPAT’s ability to affinity purify oxidized
proteins from a mixture as complex as a cell lysate.

Introduction
Oxidative damage to proteins can lead to aggregation, denaturation and
degradation of the protein. Such damage can result in loss of protein function, disruption
of cell signaling, and eventual cell death. For these and additional reasons, protein
oxidation has been implicated in the development of various pathologies including
ischemia/reperfusion, aging, cataract formation, etc. Although protein oxidation has been
associated with numerous human diseases, a definitive casual role of protein oxidation in
many diseases is still lacking. This disparity between protein oxidation and pathology
might only be resolved when new methods become available for the analysis of modified
proteins. Protein oxidation research is a formidable challenge to researchers because of
the low stoichiometry of this modification and the high heterogeneity of the resulting
protein population. One specific impediment in analysis of oxidation research is the
inability to isolate and identify the oxidized proteins and their modified peptides. It
therefore becomes requisite to develop more efficient techniques for the analysis of
oxidatively damaged proteins.
Currently the primary method used to study protein oxidation involves the use of
2,4-dinitrophenylhydrazine (DNPH).[Shacter, 2000] DNPH derivatizes non-backbone
carbonyl groups on protein residues, a common form of oxidative damage. DNPderivatized peptides can then be detected spectrophotometrically or with anti-DNP
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antibodies. Although DNPH has been useful in the analysis of protein oxidation, it is
only an identifier of protein oxidation.
To further oxidation research we have developed a novel method for the isolation
and identification of oxidized proteins using an Oxidized Protein Affinity Tag (OPAT).
Similarly to DNPH, OPAT employs a hydrazine moiety to derivatize oxidized proteins,
thereby acting as an identifier of oxidative damage. However, unlike DNPH, OPAT has
been conjugated to biotin, facilitating isolation of oxidized proteins through a
biotin/avidin interaction.
We herein report a comparison of DNPH and OPAT in the detection of protein
oxidation as well as demonstrate OPAT’s ability to affinity purify oxidized proteins from
a mixture as complex as a cell lysate.

Materials and Methods
OPAT Synthesis - The reagent that we use as our oxidized protein affinity tag (OPAT) is
4-(biotinamido) phenylacetylhydrazide (BPH), the synthesis of which was previously
described by Shinohara et al.[Shinohara, 1996] The synthesis of BPH was performed by
David Harris and is outlined in Figure 4-1. Briefly, p-aminophenyl-acetic acid
(compound 1) was esterified to yield 4-aminophenylacetic acid methyl ester
hydrochloride (compound 2). Biotin was coupled with compound 2 to yield 4(biotinamido)phenyl-acetic acid methyl ester (compound 3). Hydrazinolysis of
compound 3 yielded 4-(biotinamido)phenylacetylhydrazide (BPH). BPH was solubilized
by sonicating in 70% 2N HCl and 30% dimethylsulfoxide for use in derivatization
procedures. BPH was stored in the dark at 4°C because of its light sensitivity.
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Figure 4-1. Synthesis of 4-(biotinamido)phenylacetylhydrazide (BPH). P-aminophenyl-acetic acid
(compound 1) was esterified to yield 4-aminophenylacetic acid methyl ester hydrochloride (compound 2).
Biotin was coupled with compound 2 to yield 4-(biotinamido)phenyl-acetic acid methyl ester (compound
3). Hydrazinolysis of compound 3 yielded 4-(biotinamido)phenylacetylhydrazide (BPH). This figure was
recreated from Shinohara 1996.

Oxidative Damage to Proteins and Derivatization with OPAT and DNPH - Oxidative
damage to ovalbumin and bovine serum albumin (BSA) was accomplished by incubating
the protein for 30 minutes at 37°C in the following concentrations of sodium
hypochlorite; 1, 3, 10, 30, 100, 300, 1000 mM. The proteins were then derivatized by
incubating in either 3 mM 2,4-dinitrophenylhydrazine(DNPH) or 3 mM OPAT for 1 hour
at room temperature. The proteins were precipitated by adding 20% (v/v) trifluoroacetic
acid, and the pellets were resuspended in Laemmli buffer (3% SDS, 0.17 M Tris pH 6.8,
35% glycerol, 3.5% 2-mercaptoethanol) and 2M Tris (to neutralize the pH) and loaded
onto a 10% SDS-PAGE gel (8.3 x 6.4 x 0.1 cm).
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Immunoblots - Proteins were transferred to nitrocellulose blots and stained for total
protein by incubating in 0.1% fast green in 10% acetic acid and 30% ethanol and
destained in 10% acetic acid and 30% ethanol. The blots were then washed with TBS-T
blocked with 5 mg/mL BSA and incubated in either 1:1,000 dilution of α-DNP (Sigma,
St. Louis) for 3 hours and then a 1:10,000 dilution of goat anti-rabbit antibody, or a
1:1000 dilution of streptavidin-horse radish peroxidase (HRP) conjugate (Calbiochem,
Darmstadt) in TBS-T for 1 hour.
Densitometry of the lanes was determined using ImageMaster 2D Platinum software (GE
Healthcare, Piscataway, NJ), the background signal (from the zero HOCl added reaction)
was subtracted, and the signal was normalized to the maximum signal observed. The
data were plotted and fit to the equation y=ax/(b+x), where a=maximum signal and b is
defined as the [HOCl] yielding half-maximal binding, using Kaleidograph software
(Synergy Software, Reading, PA). The data plotted represent the mean and mean
standard error of three independent measurements.

Dynabead Protocol - Ovalbumin was oxidized by incubating in 30 mM sodium
hypochlorite, acetone precipitated and resuspended in 3% SDS. HEK 293 cell lysate
(100μg) was added to the ovalbumin and the sample was derivatized by incubating in 3
mM OPAT for 1 hour at room temperature. Two control samples, used to detect nonspecific binding, contained 1) 100 μg of HEK 293 cell lysate and 3 mM OPAT without
oxidized ovalbumin, and 2) oxidized ovalbumin and 100 μg HEK 293 cell lysate without
OPAT. After derivitization the samples were acetone precipitated and resuspended in
8M urea. Once the proteins were solubilized the 8M urea was diluted to 2M urea. M-
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280 streptavidin beads (Dynal Biotechn, Oslo, Norway) were washed 3 times with 0.01%
tween-20 in PBS and then added to the samples which were placed on a rocker and
incubated with the dynabeads for 30 minutes at room temperature. The samples were
then washed 3 times with 0.01% tween-20 in PBS with 10 minute incubations on a rocker
between each wash. After the final wash, the enriched oxidized proteins bound to the
dynabeads were resuspended in 100 mM ammonium bicarbonate and then incubated first
in 4mM dithiothreitol at 60°C for 15 min and next in 10mM iodoacetamide at room
temperature for 15 min. The beads were then washed with 100 mM ammonium
bicarbonate and incubated in 2M urea, 25mM ammonium bicarbonate and 10% w/w
trypsin overnight at 37°C.

Mass Spectrometry - Peptides were injected onto a Jupiter C18 reversed-phase resin
capillary column (150 μm ID, made in-house), and eluted using a gradient of 5 to 95%
acetonitrile in 0.1% formic acid at a flow rate of 5 μl/min using a LC Packing Ultimate
pump system. On-line mass spectrometric analysis was performed on an Applied
Biosystems QSTAR Pulsar i (Foster City, CA) using an API (atmospheric pressure
ionization) source. Automated tandem mass spectrometry using information-dependent
acquisition was run, collecting CID spectra for the three most intense ions from each
survey scan excluding peaks chosen in the preceding 2 min. Fragmentation spectra were
submitted to the Mascot (Matrix Science) website (www.matrixscience.com) for peptide
identification.
The number of peptides identified from each protein was used for spectral
counting data. Spectral counting has been shown to be an effective method to relatively
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quantify protein abundance in a sample. [Old, 2005] The method is based on the
assumption that the more abundant a protein is in a complex mixture, the more frequently
its proteolytic peptides will be identified. It is therefore an indirect way to infer protein
abundance.

Results
We have developed a novel method for the isolation and identification of oxidized
proteins using BHP (shown in Figure 4-2) as an Oxidized Protein Affinity Tag (OPAT).
OPAT employs a hydrazine moiety to derivatize oxidized proteins, thereby acting as an
identifier of oxidative damage. OPAT has also been conjugated to biotin, facilitating
isolation of oxidized proteins through a biotin/avidin interaction.

O

HN

NH

NH

O
O
NH

DNPH-like moiety binds
protein carbonyls that
result from oxidation
Biotin moiety allows for
the separation, extraction,
and detection of oxidized
proteins bound to the
OPAT molecule

S

NH2

Figure 4-2. 4-(biotinamido) phenylacetylhydrazide (BHP) as an Oxidized Protein Affinity Tag
(OPAT). Our OPAT molecule has two functional ends; 1) a hydrazine moiety which derivatizes
oxidized proteins, thereby acting as an identifier of oxidative damage, and 2) a biotin moiety which
facilitates isolation of oxidized proteins through a biotin/avidin interaction.

Qualitative comparison of ovalbumin derivatized with DNPH and OPAT (Figure
4-3) indicates that these two reagents are comparable in detecting oxidized proteins. In
each blot the left lane is protein alone, the middle lane is protein with derivatizing
reagent, and the right lane is protein oxidized with sodium hypochlorite with derivatizing
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reagent added. There is some signal in the unoxidized protein lanes, derivatized with
OPAT or DNPH, indicating an endogenous level of oxidative damage to these proteins.
The lack of signal in the protein only lanes shows the high specificity of the detection.

protein

protein
+DNPH

oxidized
protein
+DNPH

protein

118
79

118
79

47

47

33

33

25

25

protein
+OPAT

oxidized
protein
+OPAT

Figure 4-3. Qualitative comparison of derivatization with DNPH and OPAT. In each blot the left lane
is bovine serum albumin (BSA) alone, the middle lane is BSA with derivatizing reagent, and the right
lane is BSA oxidized with 1mM HOCl with derivatizing reagent added. There is some signal in the
unoxidized protein lanes, derivatized with OPAT or DNPH, indicating an endogenous level of oxidative
damage to these proteins. The lack of signal in the protein only lanes shows the high specificity of the
detection.

The amount of oxidation detected by OPAT and DNPH, when various
concentrations of HOCl were used to oxidize ovalbumin, was quantified by densitometry
of the immunoblot lanes. These values were plotted and fit to an equation for a saturating
process, shown in Figure 4-4. This revealed that the concentration of sodium
hypochlorite at which half the maximal oxidation was detected was 93 ± 31 mM for
DNPH and 33 ± 9.9 mM for OPAT. This indicates that OPAT is at least as efficient as
DNPH at derivatizing oxidized protein.
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Figure 4-4. Quantitative comparison of derivatization with DNPH and OPAT. Ovalbumin was
oxidatively damaged using various concentrations of HOCl and subsequently derivatized and detected
using either DNPH or OPAT. Densitometry of blots using ImageMaster software was done on each
lane, the background signal (from the zero HOCl added reaction) was subtracted, and the signal was
normalized to the maximum signal observed. In addition to the data points, graphs display curves fit to
the equation y=ax/(b+x), where a=maximum signal and b is defined as the [HOCl] yielding halfmaximal binding (b=92.718 ± 30.507 for DNPH and 33.072 ± 9.871 for OPAT, indicating that OPAT is
at least as efficient as DNPH at derivatizing oxidized protein).

Next we set out to use the OPAT reagent to enrich an oxidized protein from a
complex mixture. Ovalbumin was oxidized, added to HEK 293 cell lysate and the entire
sample was derivatized with OPAT. Control samples, used to detect non-specific
binding, contained cell lysate and OPAT without oxidized ovalbumin, or oxidized
ovalbumin and cell lysate without OPAT. The oxidized proteins were enriched using
magnetic dynabeads conjugated to streptavidin and identified using mass spectrometry.
The number of peptides identified from each protein was used for spectral counting data.
Figure 4-5 lists the proteins that were identified in the samples with or without OPAT and
shows spectral counting of the peptides. Spectral counting of the samples showed that
ovalbumin was the only protein which specifically bound to the dynabeads. Bovine
serum albumin was identified in all of our samples because it is used to coat the outside
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of the dynabeads. A few proteins were found to non-specifically bind to the beads,
probably due to endogenous levels of oxidation or non-specific interactions with the
beads. No proteins were detected that bound to the dynabeads from the control sample
that contained cell lysate and OPAT. Although this is most likely due to the modest
quantity of oxidation, because we know there is some endogenous oxidation in these
cells.

Spectral Counting
25

# of peptides

20

15

10

5

No OPAT

OPAT

actin,
cytoplasmic
1

elongation
factor 1
alpha

trypsin

albumin

ovalbumin

ATP
Synthase F1
delta

trypsin

albumin

0

Figure 4-5. Spectral counting of
proteins enriched with OPAT.
Ovalbumin was oxidatively
damaged using HOCl and added to
HEK 293 cell lysate. Samples were
either incubated with OPAT or not.
Magnetic beads coupled to
streptavidin were used to remove
any OPAT bound proteins. The
enriched proteins were digested and
analyzed on a mass spectrometer.
Spectral counting was used to
relatively quantify protein
abundance in the samples. The
oxidized ovalbumin was enriched
using the OPAT reagent. A few
proteins were found to nonspecifically bind to the beads.
Bovine serum albumin is detected
because the magnetic beads are
coated with it to reduce non-specific
binding.

Discussion
We have developed a method for the detection and enrichment of oxidized
proteins. This method utilizes the reagent BPH as an oxidized protein affinity tag
(OPAT) that not only derivatizes protein carbonyls, but that also tags them with a biotin
affinity tag. The OPAT reagent has been shown to derivatize and detect oxidatively
damaged proteins as efficiently as the standard reagent used for detection of protein
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carbonyls (DNPH). Using the affinity tag, we have been able to enrich OPATderivatized proteins from a mixture as complex as a cell lysate and identified them using
mass spectrometry.
As oxidized proteins can often represent a minor fraction of the total protein
population, they are often masked by other more abundant proteins. Also, because
protein oxidation does not typically result in a homogeneous population of modified
protein, the amount of protein in a single modification state can be a very small fraction
of the total protein present. The affinity tag on the OPAT molecule helps to overcome
these impediments by enabling enrichment of the oxidized proteins from a complex
sample.
Once the modified proteins have been enriched, enzymatic digestion of the
proteins into peptides followed by fragmentation of the peptides using mass spectrometry
would allow identification of the residues on which the modifications lie. This method
would also provide insight into the nature of the modification as well as suggest a
possible oxidizing source.
Recently, 2D-oxyblots have been proposed as a proteomic approach to study
oxidatively damaged proteins. This process employs two-dimensional gel electrophoresis
(2DE) for the separation and resolution of oxidized proteins which are then detected
using immunoblotting techniques. We have previously shown that 2DE is severely
limited in its ability to resolve microheterogeneous proteins into detectable spots
[Warburton, 2005]. Oxidized proteins appear as smears on 2D gels instead of focused
spots. This can lead to inaccurate conclusions when the non-specific binding of an
antibody to a well-focused protein gives a false positive or when proteins are not
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accurately correlated between a gel and an immunoblot. Our OPAT reagent will provide
a superior alternative to 2D-oxyblots for the analysis of these proteins.
The development of this method will prove useful in the advancement of protein
oxidation research by assisting in the isolation and identification of protein oxidation
associated with various pathologies. This method may also help establish definitive ties
between certain pathologies and oxidative modifications.
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CHAPTER 5
PROTEOMIC AND PHENOTYPIC ANALYSIS OF RPE CELLS

Summary
The retinal pigment epithelium is a monolayer of cells located directly behind
photoreceptor cells in the retina. During embryongenesis these cells differentiate to form
a polarized epithelium. Once epithelialized, RPE cells have little or no turn over for the
remainder of the organism’s life. Although RPE cells in the adult monolayer are
quiescent, the cells are capable of proliferating when placed in culture. When RPE cells
are removed to culture there is a rapid loss in polarity and epithelial phenotype.[Huotari,
1995; Burke, 1996] However, researchers have been able to induce differentiation of
RPE cells in culture through the use of humoral substances, substrate association or
tissues interactions.[Campochiaro and Hackett, 19931; Song and Lui, 1990] Although
cultured human RPE cells can be induced to differentiate the process is costly and time
consuming and as a result most scientists perform research on undifferentiated RPE cells.
The following chapter details the proteomic differences in differentiated and
undifferentiated ARPE-19 cells (the only human RPE cell line available for research) and
compares these results to the proteome of human RPE cells. The phenotypic differences
of these cells as revealed by transmission electron microscopy are also reported.
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Introduction
During ocular development, signaling events induce RPE morphogenesis to
produce a fully differentiated monolayer of tightly packed cells. Signals for these events
have not been completely established, but it has been shown that cues from adjacent
tissues contribute to the development of an epithelial organization and polarity in these
cells.[Rizzolo and Heiges, 1991] The lateral, apical and basal cell surfaces in the RPE
monolayer are functionally and structurally specialized. Neighboring RPE cells are
linked at their lateral margins by tight junctions, enabling these cells to act as a selective
barrier. The plasma membrane on the basal surface is highly infolded and lies adjacent to
Bruch’s membrane. The apical surface consists of microvilli that interdigitate with
photoreceptor outer segments and assist in their phagocytosis. These structural
specializations are necessary for proper RPE functioning. Once epithelialized, RPE cells
have little or no turnover for the remainder of the organism’s life.
Although RPE cells in the adult monolayer are quiescent, the cells are capable of
proliferating when placed in culture. When RPE cells are removed to culture there is a
rapid loss in polarity and epithelial phenotype.[Huotari, 1995; Burke, 1996] However,
researchers have been able to induce differentiation of RPE cells in culture through the
use of humoral substances, substrate association or tissues interactions.[Campochiaro and
Hackett, 19931; Song and Lui, 1990]
Currently the only human RPE cell line available for research is the ARPE-19 cell
line. Although cultured RPE cells can be induced to differentiate, the process is costly
and time consuming. As a result most investigators perform research on undifferentiated
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RPE cells in culture. To ascertain the proteomic differences in differentiated and
undifferentiated ARPE-19 cells, we have examined the proteomes from these cells and
compared them to the proteome of human RPE cells. These proteomic results were also
compared to the phenotypic characteristics of these cells detected by transmission
electron microscopy (TEM).

Materials and Methods
ARPE-19 Differentiation-ARPE-19 (human retinal pigment epithelial cells – ATCCCRL-2302) cells were grown in T-75 tissue culture flasks in RPMI 1640 media
supplemented with 10% fetal bovine serum (FBS). Undifferentiated cells were harvested
at 95% confluency. The cells were differentiated by transferring the confluent cells to
T75 flasks coated with matrigel and reducing the FBS in the media to 1%. Cells were
allowed to differentiate for 3 weeks. Cells were solubilized in either 3% SDS or
phosphate buffered saline (PBS) containing 2.3 µM E-64 and 0.6 mM PMSF to examine
either the complete proteome or the soluble proteome of the cells, respectively.

2D Gel Electrophoresis and Mass Spectrometry- 100 μg of ARPE-19 cell lysate was
acetone precipitated and solubilized in reswelling buffer (7 M urea, 2 M thiourea, 15 mM
dithiothreitol (DTT), 1% pharmalites, 0.5% Triton X-100 and 2% ASB-14 (Calbiochem,
San Diego, CA)). Immobilized pH gradient (IPG) strips (pH 4-7, 7 cm) were rehydrated
in this solution for 12 h under mineral oil. Isoelectric focusing (IEF) was performed at
20°C, on a Multiphor II Electrophoresis System (Amersham Pharmacia Biotech,
Piscataway, NJ). A programmed voltage gradient was used consisting of 200 V for 1 min,
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linearly increasing to 3500 V over 1.5 h, and held at 3500 V for 1.5 h to reach a total of
approximately 8 kVh. Following isoelectric focusing, IPG strips were washed in
equilibration buffer (0.05 M Tris, 6 M urea, 30% glycerol, and 1% SDS) containing 32
mM dithiothreitol for 15 min followed by a 15 min wash in equilibration buffer
containing 216 mM iodoacetamide. The proteins were then separated according to their
molecular weight on a 10% gel (8.3x6.4x0.1 cm) using standard SDS-PAGE conditions.
Gels were stained with colloidal coomassie (Pierce), and gel spots were excised for
analysis. Excised spots were trypsinized in-gel [Schevchenko, 1996] and desalted using a
ZipTipU-C18 (Millipore, Bedford, MA). Sample spots of 1 μl were allowed to cocrystallize on the MALDI plate with 1 μl of α-cyano 4-hydroxycinnamic acid as the
matrix. The peptides were analyzed by oMALDI Qq-ToF (orthogonal matrix-assisted
laser desorption ionization quadrupole time-of-flight) mass spectrometry on an Applied
Biosystems QSTAR Pulsar i instrument (Foster City, CA).

Analysis of 2D Gels - 2D gels were analyzed using Image Master software (GeneBio,
Geneva, Switzerland). Image Master calculates the volume of a spot as the volume above
the spot border, situated at 75% of the spot height (measured from the peak of the spot).
The spot volumes were then used to determine the percent volume of each spot in the
gels. The percent volume of a spot was calculated as the volume of the spot divided by
the combined volumes of all spots in the gel, multiplied by one hundred. Percent volume
was used to semi-quantitatively determine the protein abundance of spots in the gels.
Internal pI and molecular weight standards were used to assist in the alignment of gels.
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Microscopy of Differentiated and Undifferentiated ARPE-19 Cells - ARPE-19 cells were
grown on either membrane alone in media containing 10% FBS until confluent
(undifferentiated) or membrane coated with matrigel in media containing 1% FBS for
three weeks (differentiated). Cells on the membrane were fixed in glutaraldehyde,
postfixed in osmic acid, dehydrated, and embedded in epoxy resin. Slices of the samples
(100 nm) were imaged and photographed on a JEOL JEM 2000 FX scanning electron
microscope.

Results
The proteins in undifferentiated and differentiated ARPE-19 cells and human RPE cells
were harvested and fractionated on 2D gels, shown in Figure 5-1. Initially, the complete
proteome of the aforementioned cells (as harvested with 3% SDS) was analyzed.
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DIF

RPE

complete

UND

DIF

RPE

soluble

UND

Figure 5-1. 2D gels of undifferentiated (UND) ARPE-19, differentiated (DIF) ARPE-19 and human
RPE cells (RPE). The cells were solubilized in either 3% SDS or phosphate buffered saline (PBS)
containing 2.3 µM E-64 and 0.6 mM PMSF to examine either the complete proteome or the soluble
proteome of the cells, respectively.

However, because of the high number of cytoskeletal proteins identified, we undertook
the analysis of the soluble proteome of these cells by harvesting the proteins in phosphate
buffered saline (PBS). The spots that were excised and analyzed by mass spectrometry
from the 2D gels are indicated on the gels in Figures 5-2A-C. The proteins identified in
each of the six gels, along with the proteins subcellular location, tissue specificity,
synonyms, ascession number and function are listed in Tables 5-1A-F (located at the end
of the results section in this chapter).

92

soluble

complete

undifferentiated

Figure 5-2A. 2D gels of complete and soluble proteome of
undifferentiated ARPE-19 cells. The spot location and identification
number are indicated on the gel.
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soluble

complete

differentiated

Figure 5-2B. 2D gels of complete and soluble proteome of differentiated
ARPE-19 cells. The spot location and identification number are indicated
on the gel.
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soluble

complete

human RPE

Figure 5-2C. 2D gels of complete and soluble proteome of human RPE
cells. The spot location and identification number are indicated on the
gel.
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To assess the relatedness of the proteomes, Venn diagrams were used to display the
number of proteins in common to each other, Figure 5-3.

Complete Proteome
UND
24

DIF
7

9

Soluble Proteome
UND
9

DIF
13

1

UND
27

3

RPE
25

DIF
16

8

22

6

19
6

Complete & Soluble Combined

8

2

RPE
23

8

3

RPE
36

Figure 5-3. Venn diagrams of proteins identified in differentiated ARPE-19 (DIF),
undifferentiated ARPE-19 (UND) and human RPE cells (RPE). Proteins in DIF, UND or RPE
cells were solubilized in either 3% SDS or PBS with protease inhibitors to examine the
complete or soluble proteome, respectively.

The ten most abundant, non-cytoskeletal, proteins from each gel were established by
determining the percent volume of each spot using ImageMaster software and are listed
in Table 5-2. The cytoskeletal proteins that were excluded from Table 5-2 include actin,
tubulin, vimentin and tropomyosin.
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Complete Proteome
undifferentiated

differentiated

RPE

spot protein
E136 calreticulin

%Vol
4.669

spot
H1

protein
calreticulin

%Vol
3.113

E40
E132
E20
E117

protein disulfide isomerase
protein disulfide isomerase
heat shock 70 protein 5
nucleophosmin 1

1.480
1.413
1.156
1.040

H112
H73
H56
H74

annexin A5
cathepsin H
enolase
glutathione S-transferase

1.473
1.278
1.174
1.052

E91
E29

ATP synthase beta subunit
mitochondrial matrix protein P1

0.992
0.920

H7
H14

myosin, heavy polypeptide 9
myosin, heavy polypeptide 9

0.880
0.834

E116 nucleophosmin 1

0.757

H2

E1
E58

0.736
0.724

heat shock protein 70 gp96
heat shock protein 27

protein disulfide isomerase
precursor
H107 heat shock 70 protein 5
H34 heat shock protein gp96

spot
Z72

%Vol
4.040

0.775

protein
ATP synthase, H+ transporting,
mitochondrial F1 complex, beta
subunit
Z93 annexin A5
Z76 enolase
Z64 creatine kinase
Z46 3-hydroxyisobutryrate
dehydrogenase
Z35 peroxiredoxin 2
Z103 ATP synthase, H+ transporting,
mitochondrial F1 complex, beta
subunit
Z40 recoverin

0.702
0.662

Z89
Z52

14-3-3
tripeptidyl peptidase 1

1.832
1.703

3.681
3.379
2.467
2.263
2.187
2.118

1.977

Soluble Proteome
undifferentiated
spot
J69
J52
J92
J1
J32
J31
J53
J30
J39
J105

differentiated

RPE

protein
glyceraldehyde 3-phosphate
dehydrogenase
glutathione-s-transferase
protein kinase
calreticulin
annexin A5
annexin A5
glutathione s-transferase

%Vol
2.630

spot
A59

protein
annexin A5

%Vol
4.854

spot
K97

protein
heat shock 70 protein 8

%Vol
2.035

2.060
1.982
1.721
1.298
1.257
1.008

A60
A87
A56
A49
A48
A105

annexin A5
glutathione-s-transferase
14-3-3
enolase
enolase
phosphoglycerate mutase 1

3.635
2.794
1.986
1.476
1.302
1.243

K32
K14
K72
K46
K24
K52

1.562
1.488
1.486
1.350
1.079
0.990

glyceraldehyde 3-phosphate
dehydrogenase
14-3-3
heat shock 70 protein 8

0.940

A85

phosphoglycerate kinase 1

1.238

K15

glutathione s-transferase
tripeptidyl peptidase
calreticulin
14-3-3
glutathione s-transferase
glyceraldehyde 3-phosphate
dehydrogenase
lactate dehydrogenase C

0.917
0.809

A47 enolase
A104 cathepsin H

1.153
1.030

K43
K26

retinaldehyde binding protein
peroxiredoxin 2

0.899
0.792

0.960

Table 5-2. Ten most abundant spots in 2D gels. The ten most abundant, non-cytoskeletal, proteins from each gel
were established by determining the percent volume of each spot using ImageMaster software Initially the
volume of a spot was calculated as the volume above the spot border, situated at 75% of the spot height
(measured from the peak of the spot). The spot volumes were then used to determine the percent volume of each
spot in the gels. The percent volume of a spot was calculated as the volume of the spot divided by the combined
volumes of all spots in the gel, multiplied by one hundred. Percent volume was used to semi-quantitatively
determine the protein abundance of spots in the gels. The cytoskeletal proteins that were excluded are actin,
tubulin, vimentin and tropomyosin.

The phenotypic characteristics of differentiated and undifferentiated ARPE-19
cells were examined using transmission electron microscopy (TEM), Figure 5-4. This
enabled a qualitative comparison of the specialized structures on these cells which are
required for proper RPE functioning. Specifically cell size, cell shape and the presence
or absence of apical microvilli where among the characteristics examined.
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7.0 um

undifferentiated ARPE-19

differentiated ARPE-19

Figure 5-4. Transmission electron micrograph (TEM) of differentiated and undifferentiated ARPE19 cells. ARPE-19 cells were grown on either membrane alone in media containing 10% FBS until
confluent (undifferentiated) or membrane coated with matrigel in media containing 1% FBS for
three weeks (differentiated). Cells on the membrane were fixed in glutaraldehyde, postfixed in
osmic acid, dehydrated, and embedded in epoxy resin. Slices of the samples (100 nm) were
imaged and photographed on a JEOL JEM 2000 FX.

Table 5-1A. Proteins identified from the complete proteome of undifferentiated ARPE-19 cells.
Protein
NCBI
Spot
synonym
subcellular
tissue
function
asscession
location
specificity
14-3-3
AAD48408
E99, E100,
cytoplasm
widely
adapter protein
E101,
expressed implicated in
E102
regulation of
signaling pathways
3-hydroxyisobuty- NP_689953
E52
Mitochondcatalytic enzyme
rate
rion
dehydrogenase
6AAH14006
E55
hydrolyzes 6phosphogluconophosphogluconolactonase
lactone
actin, beta
CAA45026
E29, E33,
cytoplasm
ubiquitous involved in cell
E34, E44,
motility
E84, E86,
E87, E93,
E110,
E120
annexin A1
1AIN
E46, E139,
promotes membrane
E140
fusion, involved in
exocytosis and
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annexin A3

NP_005130

E51

annexin A5
ATP synthase beta
subunit

AAH18671
AAA51808

E97
E91

calreticulin

AAP36116

E136

calumenin

AAB97725

E111

cathepsin D

AAP35556

cathepsin H

CAA30428

E52, E75,
E76, E79
E57

chaperonin
containing TCP1,
subunit 5

NP_036205

E18

KIAA009
8 protein

dynactin 2

NP_006391

E92

DCTN2
protein,
p50
dynamitin

enolase

CAA32505

E128

eukaryotic
translation
initiation factor 3,
subunit 2 beta

AAH00413

E48

F-actin capping
protein alpha-1
subunit

NP_006126

E49

glutathione Stransferase

CAA30894

E64, E65

heat shock 70

NP_005337

E13, E23

H(+)transporting
ATPase
beta
subunit

crocalbin

regulates
phospholipase A2
inhibitor of
phospholipase A2,
possesses anticoagulation
properties
anticoagulant
produces ATP from
ADP in the
presence of a proton
gradient across the
membrane

Mitochondrion

cytoplasm,
nucleus,
mitochondria

widely
expressed

endoplasmic
reticulum

ubiquitous

lysosome
lysosome

cytoplasm,
peripheral
membrane
protein

cytoplasm
PRO2242

dnaK-type
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probable
oxidoreductase and
plays a role in
apoptosis
involved in
regulation of
carboxylation to
amino acid residues
breaks down
proteins
degrades proteins in
lysosomes
molecular
chaperone involved
in folding of actin
and tubulin
modulates
cytoplasmic dynein
binding to an
organelle and plays
a role in
prometaphase
chromosome
alignment and
spindle organization

most adult
tissues
binds the 40S
ribosome and
promotes the
binding of tRNAi
and mRNA
binds end of actin
filaments, blocking
the exchange of
subunits
conjugates reduced
glutathione to
hydrophobic
electrophiles
stabilizes proteins

protein 1B

molecular
chaperone

against aggregation
and mediates
protein folding
involved in folding
and assembly of
proteins in the ER

heat shock 70
protein 5

NP_005338

E20

glucose
regulated
protein,
BiP,
dnaK-type
molecular
chaperone
dnaK-type
molecular
chaperone
, mortalin2

heat shock 70
protein 9B

AAH30634

E12

heat shock protein
27

AAA62175

E58, E65

heat shock protein
gp96

AAK74072

E1

lactate
dehydrogenase B

AAH71860

E46

cytoplasm

laminin-binding
protein
mannose 6
phosphate
receptor binding
protein 1

CAA43469

E121

cytoplasm

AAH01590

E87

cytoplasm

mitochondrial
matrix protein P1

NP_002147

E28, E29

nucleophosmin 1

AAH12566

E96, E116,
E117

peroxiredoxin 2

CAA80269

E63

mediates protein
folding

cytoplasm,
nucleus
glucoseregulated
protein
94,
GRP94,
tumor
rejection
antigen 1

Heat
shock
protein
60,
chaperonin

endoplasmic
reticulum

mitochondrio
n

nucleus

thiolspecific
antioxidant protein

100

cytoplasm

involved in stress
resistance and actin
organization
molecular
chaperone that
functions in the
processing and
transport of secreted
proteins
catalytic enzyme
involved in
anaerobic glycolysis
possibly involved in
cell adhesion
required for
transport of
mannose 6phosphate receptors
from endosomes to
the trans-Golgi
network
involved in
mitochondrial
protein import,
macromolecular
assembly and
correct folding of
imported proteins
associated with
nucleolar
ribonucleoprotein
structures and binds
single stranded
nucleic acids
involved in redox
regulation; reduces
peroxides

peroxiredoxin 4

CAG46469

E56

peroxiredoxin 6

NP_004896

proliferating cell
nuclear antigen

Thioredoxin
peroxidease

cytoplasm

involved in redox
regulation; reduces
peroxides

E59

cytoplasm

CAG38740

E112

nucleus

proteasome
activator subunit 1
isoform 1
protein disulfide
isomerase

NP_006254

E55

involved in redox
regulation; reduces
peroxides
involved in
regulation of DNA
replication
involved in
cleavage of proteins

BAA03759

E39, E40

protein disulfide
isomerase
precursor

NP_000909

E131,
E132

protein disulfide
isomerase-related
protein 5

AAB50217

E91, E92

protein kinase C
substrate
pyridoxal kinase

AAA98668

E135

NP_003672

E46

pyruvate
dehydrogenase,
chain D
rho GDP
dissociation
inhibitor alpha
SET translocation

1NI4D

E49

AAP35530

E70

NP_003002

E109

tat-associated
protein
Tat-binding
protein-1
transformation
upregulated
nuclear protein

2110369A

E108

107855

E92

CAA51267

E17, E24,
E25,

transformation

AAH03394

E94

Phospholipase c
alpha,
glucose
regulated
protein
prolyl 4hydroxyla
se

endoplasmic
reticulum

catalyzes the
rearrangement of
disulfide bonds in
proteins

endoplasmic
reticulum

catalyzes the
formation,
rearrangement and
breakage of
disulfide bonds
catalyzes the
rearrangement of
disulfide bonds in
proteins
regulatory subunit
of glucosidase II
required for
synthesis of
pyridoxal-5phosphate from
vitamin B6

endoplasmic
reticulum

Chromosome 21
open
reading
frame 97

cytoplasm

cytoplasm
myeloid
leukemiaassociated
PSMC3
protein
heterogen
eous
nuclear
ribonucleo
protein K,
isoform B
Hetero-

101

nucleus

ubiquitous

regulates GDP/GTP
exchange reaction
of Rho proteins
possibly involved in
nucleosome
assembly

cytoplasm,
nucleus

pre-mRNA binding
protein, plays a role
in nuclear
metabolism of
hnRNAs

nucleus

binds pre-mRNA

upregulated
nuclear protein

geneous
nuclear
ribonucleo
-protein C
Heterogeneous
nuclear
ribonucleo
-protein H

and nucleates the
assembly of hnRNP
particles

transformation
upregulated
nuclear protein

NP_062543

E133

translation
elongation factor
eEF-1 delta
tropomyosin 1

1085404

E95

possible signal
transducer

A23562

E103

tropomyosin 3

A27674

E114

tropomyosin 4

NP_003281

E104

tubulin, alpha

CAA25855

tubulin, beta

0805287A

ubiquitin
thiolesterase

A25856

E74, E88,
E89, E90
E129,
E130
E66

UMP-CMP kinase

AAH14961

E63

vimentin

NP_003371

VLA-3 alpha
subunit

BAA00845

E32, E80,
E82, E88,
E89, E90,
E118,
E119
E7, E8, E9,
E10, E11

binds to actin
filaments
binds to actin
filaments
binds to actin
filaments
major constituent of
microtubules
major constituent of
microtubules
ubiquitin
thiolesterase
activity
catalyzes
phosphoryl transfer
from ATP to UMP
and CMP
class three filaments
found in various
non-epithelial cells

WD-40 repeat
protein

BAA75544

E94

WW domain
binding protein-2

AAD10951

E45

nucleus

nucleus,
cytoplasm

a component of the
hrRNP complex
which processes
pre-mRNAs

ubiquitous

widely
expressed

Integrin
alpha-3
precursor

membrane

widely
expressed

receptor for
fibronectin, laminin,
collagen, epiligrin,
thrombospondin
and CSPG4
interacts with RNA
binding protein

ubiquitous

binds to the WW
domain of YAP1,
WWP1, and WWP2

serine/
threonine
kinase
receptor
associated
protein
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Table 5-1B. Proteins identified from the complete proteome of differentiated ARPE-19 cells.
protein
NCBI
spot
synonym
subcellular tissue
asscession
location
specificity
14-3-3
AAD48408
H109, H117 cytosolic
cytoplasm
widely
phosphoexpressed
lipase A2
actin, beta
CAA45026
H18, H22,
cytoplasm
ubiquitous
H24, H35,
H36, H38,
H40, H41,
H42, H43,
H44, H45,
H47, H48,
H50, H51,
H52, H58,
H62, H63,
H72, H80,
H81, H82,
H83, H84,
H88, H90,
H91, H95,
H96, H110,
H113,
H114,
H115, H116
alpha-actinin
CAA38970
H28
cytoplasm

annexin A3

NP_005130

H68, H70

annexin A4

NP_001144

H68, H69

annexin A5

AAH18671

H112, H113

ATP synthase beta
subunit

AAA51808

H78, H83

calreticulin
precursor

NP_004334

H1

lipocortin
V

cytoplasm
Mitochond
-rion

calcium
binding
protein
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Endoplasm
-mic
reticulum

function
adapter protein
implicated in
signaling pathways
involved in cell
motility

F-actin crosslinking protein
thought to anchor
actin to a variety of
intracellular
structures
inhibitor of
phospholipase A2,
possesses anticoagulation
properties
promotes
membrane fusion
and is involved in
exocytosis
involved in signal
transduction and
apoptosis
produces ATP
from ADP in the
presence of a
proton gradient
across the
membrane
chaperone
promotes folding,
oligomeric
assembly and
quality control in
the ER

cathepsin B

2007265A

H89

lysosome

cathepsin D

AAP35556

H71, H96

lysosome

cathepsin H

CAA30428

H73

lysosome

dimethylarginine
dimethylaminohydrolase
enolase

NP_036269

H61

CAA32505

H32, H33,
H56, H57,
H60, H61
H71

F-actin capping
protein beta
subunit
filamin

AAA92644

H102

glutathione Stransferase

CAA30894

H74

heat shock 70
protein 5

NP_005338

H48, H54,
H55, H107,
H108

heat shock protein
27

AAA62175

H66, H72,
H73

heat shock protein
90
heat shock protein
gp96

mitochondrial
matrix protein P1

degradation of
proteins
breaks down
proteins
degrades proteins
in lysosomes
hydrolyzes
inhibitors of NOS

Dimethylarginase-1
cytoplasm

most adult
tissues

CapZB

cytoplasm

glucose
regulated
protein,
BiP,
dnaK-type
molecular
chaperone
p24k-1,
estrogen
receptor
related
protein

ubiquitous

binds to the end of
actin filaments
blocking the
exchange of
subunits
promotes
orthogonal
branching of actin
filaments and links
actin to membrane
glycoproteins
conjugates reduced
glutathione to
hydrophobic
electrophiles

cytoplasm,
nucleus

involved in stress
resistance and actin
organization

Endoplasmic
reticulum

molecular
chaperone that
functions in the
processing and
transport of
secreted proteins

Mitochond
-rion

involved in
mitochondrial
protein import,

H121
AAK74072

H34

NP_002147

H16

Tumor
rejection
antigen/
endoplasm
-mic
reticular
heat shock
protein
gp96
homolog
protein
HSP 60,
chaperonin
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myosin, heavy
polypeptide 9,
non-muscle

NP_002464

osteonectin

NP_003109

peroxiredoxin 2

CAA80269

H77, H79

peroxiredoxin 4

CAG46469

H72

protein disulfide
isomerase

BAA03759

H53, H58

protein disulfide
isomerase
precursor

NP_000909

H2, H94,
H101

protein disulfide
isomerase-related
protein 5

AAB50217

H54

pyridoxal kinase

NP_003672

H59

transglutaminase 2
isoform a
tripeptidylpeptidase I

NP_004604

H81

NP_000382

H52

tropomyosin 1

A23562

H105, H108

tropomyosin 3

A27674

H103, H104

tropomyosin 4

NP_003281

H100, H107

tubulin, alpha

CAA25855

tubulin, beta

0805287A

H76, H78,
H123
H30, H95,
H111

macromolecular
assembly and
correct folding of
imported proteins
possible ATP
binding protein,
may be involved in
motor activity
may be involved in
calcium ion
binding

H4, H5, H6,
H7, H14,
H69
Extracellular
matrix
protein
thiolspecific
antioxidant
protein
Thioredoxin
peroxidase
Phosphorlipase c
alpha,
glucose
regulated
protein
prolyl 4hydroxyase

cytoplasm

involved in redox
regulation; reduces
peroxides

cytoplasm

involved in redox
regulation; reduces
peroxides
catalyzes the
rearrangement of
disulfide bonds in
proteins

Endoplasmic
reticulum

Endoplasmic
reticulum
Endoplasmic
reticulum

Chromosome 21
open
reading
frame 97

cytoplasm

ubiquitous

ceroid
lipofuscinosis

lysosome

widely
expressed

catalyzes the
formation,
rearrangement and
breakage of
disulfide bonds
catalyzes the
rearrangement of
disulfide bonds in
proteins
required for
synthesis of
pyridoxal-5phosphate from
vitamin B6
lysosomal serine
protease
binds to actin
filaments
binds to actin
filaments
binds to actin
filaments
major constituent
of microtubules
major constituent
of microtubules
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UMP-CMP kinase

AAH14961

H77

Vimentin

NP_003371

H27, H28,
H29, H30,
H31, H33,
H63, H72,
H106,
H110,
H117, H124

nucleus,
cytoplasm

ubiquitous

widely
expressed

Table 5-1C. Proteins identified from the complete proteome of human RPE cells.
protein
NCBI
spot
synonym
subcellular
tissue
asscession
location
specificity
14-3-3
AAD48408
Z87, Z88,
protein
cytoplasm
widely
Z89, Z91
kinase C
expressed
inhibitor
protein-1
epsilon
isoform
3-hydroxyNP_689953
Z24, Z46
Mitochondisobutyrate
rion
dehydrogenase
actin, beta
CAA45026
Z43, Z60,
cytoplasm
ubiquitous
Z65, Z66,
Z67, Z68,
Z69, Z70,
Z71, Z92
aldehyde
AAC51652
Z102
cytoplasm
dehydrogenase 1

annexin A4

NP_001144

Z49

annexin A5

AAH18671

Z15, Z91,
Z93, Z95

cytoplasm

annexin A6

AAH17046

Z21

stress fibers

annexin A7

AAP35851

Z11

ATP synthase beta
subunit

AAA51808

Z29

Mitochondrion
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catalyzes
phosphoryl transfer
from ATP to UMP
and CMP
class three
filaments found in
various nonepithelial cells

function
adapter protein
implicated in
signaling pathways

catalytic enzyme
involved in cell
motility

binds free retinal
and CRALBPbound retinal; can
oxidize
retinaldehyde to
retinoic acid
promotes membrane
fusion and is
involved in
exocytosis
involved in signal
transduction and
apoptosis
associates with
CD21 and regulates
the release of Ca
from intracellular
stores
involved in calcium
ion binding
produces ATP from
ADP in the
presence of a proton
gradient across the
membrane

ATP synthase, H+
transporting,
mitochondrial F0
complex, subunit
d
ATP synthase, H+
transporting,
mitochondrial F1
complex, beta
subunit
ATPase, H+
transporting,
lysosomal, V1
subunit A
calumenin

NP_006347

Z38

Mitochondrion

catalyzes ATP
synthesis

NP_001677

Z72, Z103

Mitochondrion

catalyzes ATP
synthesis

AAP36699

Z30

lysosome

AAB97725

Z3

cathepsin B

2007265A

Z39

lysosome

cathepsin D

AAP35556

lysosome

clusterin isoform

NP_001822

Z24, Z45,
Z46
Z95

creatine kinase

AAC31758

Z19, Z62,
Z64, Z65,
Z66

endoplasmic
reticulum protein
29 precursor
enolase

NP_006808

Z48

endoplasmic
reticulum

ubiquitous

CAA32505

cytoplasm

most adult
tissues

glutathione Stransferase

CAA30894

Z11, Z16,
Z54, Z76,
Z101
Z41

glutathione-insulin
transhydrogenase

CAA30112

Z27

glyceraldehyde-3phosphate
dehydrogenase

CAA25833

Z99

guanine
nucleotide-binding
protein, beta 1

NP_002065

Z97, Z98,
Z99

crocalbin

endoplasmic
reticulum

ubiquitous

secreted
protein
cytoplasm

prolyl 4hydroxylase,
thryoid
hormone
binding
protein

endoplasmic
reticulum

cytoplasm
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involved in
regulation of
carboxylation to
amino acid residues
degradation of
proteins
breaks down
proteins
associated with
apoptosis
reversibly catalyzes
the transfer of
phosphate between
ATP and various
phosphogens
processes secretory
proteins within the
ER

conjugates reduced
glutathione to
hydrophobic
electrophiles
catalysis formation,
breakage and
rearrangement of
disulfide bonds

catalyist for
carbohydrate
degradation and
glycolysis
modulator of
various
transmembrane
signaling systems,
required for GTPase

heat shock 70
protein 1B

NP_005337

Z30

dnaK-type
molecular
chaperone

heat shock 70
protein 9B

AAH30634

Z21, Z57,
Z59

heat shock protein
27

AAA62175

Z42, Z50

heat shock protein
gp96

AAK74072

Z12

motor protein

BAA04654

Z4, Z5, Z6

NADH
dehydrogenase
(ubiquinone) Fe-S
protein 1
NADH
dehydrogenase
(ubiquinone) Fe-S
protein 3
NADH
dehydrogenase
(ubiquinone) Fe-S
protein 8
NADH
dehydrogenase
(ubiquinone)
flavoprotein 2
mitochondrial
matrix protein P1

AAH30833

Z13, Z58

NP_004542

Z42, Z43

NP_002487

Z39

NP_066552

Z47

NP_002147

Z26, Z60

dnaK-type
molecular
chaperone
, mortalin2
p24k-1,
estrogen
receptor
related
protein
tumor
rejection
antigen,
glucose
regulated
protein
Mitochondrial
inner
membrane
protein
NADHubiquinone oxidoreductase
NADHcoenzyme
Q
reductase
NADHcoenzyme
Q
reductase
NADHubiquinone oxidoreductase
Chaperonin
(HSP60)

nucleophosmin 1

AAH12566

Z81

nucleosidediphosphate

NP_000260

Z33

activity
stabilizes proteins
against aggregation
and mediates
protein folding
mediates protein
folding

cytoplasm,
nucleus

involved in stress
resistance and actin
organization

endoplasmic
reticulum

molecular
chaperone that
functions in the
processing and
transport of secreted
proteins

Mitochondrion

Mitochondrion

may be involved in
mitochondrial
electron transport
may donate
electrons to
ubiquinone
may be involved in
mitochondrial
electron transport
Mitochondrion

nucleus

nm23
protein
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large subunit of
complex where
NADH is oxidized

involved in
mitochondrial
protein import,
macromolecular
assembly and
correct folding of
imported proteins
may function in the
assembly and/or
transport of
ribosome

kinase 1 isoform b
peroxiredoxin 2

CAA80269

Z35, Z37

peroxiredoxin 6

NP_004896

Z50, Z51

prenylcysteine
oxidase 1
prohibitin

NP_057381

Z53

NP_002625

Z44

protein disulfide
isomerase

BAA03759

Z9, Z56

protein disulfide
isomerase
precursor

1MEK

Z27

RAP1B

NP_056461

Z33

recoverin

AAP88840

Z40

retinaldehydebinding protein 1

NP_000317

Z94

serum albumin
transmembrane
anchor protein 1
tripeptidylpeptidase I

CAA23754
P84157

Z8
Z1

NP_000382

Z10, Z52

tropomyosin 1

A23562

Z83, Z84

tropomyosin 3

A27674

Z85

tropomyosin 4

NP_003281

Z86

tropomyosin, beta

AAF17621

Z14

tubulin, alpha

CAA25855

tubulin, beta

0805287A

Z97, Z103,
Z104
Z25, Z61,

thiolspecific
antioxidant
protein

KIAA0908

Phosphorlipase c
alpha,
glucose
regulated
protein
prolyl 4hydroxylase,
thryoid
hormone
binding
protein
RAS
related
protein
RAP1B
guanylate
cyclase
activator
CRALBP

cytoplasm

involved in redox
regulation; reduces
peroxides

cytoplasm

involved in redox
regulation; reduces
peroxides
degradation of
prenylated proteins
inhibits DNA
synthesis, regulates
proliferation
catalyzes the
rearrangement of
disulfide bonds in
proteins

lysosome

ubiquitous

Mitochondrion

widely
expressed

endoplasmic
reticulum

endoplasmic
reticulum

catalyzes the
formation,
rearrangement and
breakage of
disulfide bonds
displays low
GTPase activity
involved in calcium
ion binding

cytoplasm

retina and
pineal
gland

carries 11-cis
retinol and 11-cis
retinaldehyde as
endogenous ligands

widely
expressed

lysosomal serine
protease

membrane
ceroid
lipofuscinosis

lysosome

binds to actin
filaments
binds to actin
filaments
binds to actin
filaments
major constituent of
microtubules
major constituent of
microtubules
major constituent of
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vimentin

NP_003371

Z62, Z63,
Z73, Z74,
Z75
Z28, Z77,
Z78, Z79

microtubules
widely
expressed

class three filaments
found in various
non-epithelial cells

Table 5-1D. Proteins identified from the soluble proteome of undifferentiated ARPE-19 cells.
protein
NCBI
spot
synonym
subcellular
tissue
function
asscession
location
specificity
14-3-3
AAD48408
J39
cytoplasm
widely
adapter protein
expressed implicated in
regulating signaling
pathways
actin, beta
CAA45026
J19, J29,
cytoplasm
ubiquitous involved in cell
J59, J60,
motility
J62, J65,
J76, J77,
J78, J79,
J80, J82,
J83, J99,
J100, J102,
J103
annexin A1
1AIN
J27, J28,
promotes membrane
J29
fusion, involved in
exocytosis and
regulates
phospholipase A2
annexin A2
AAH09564
J44, J45
secreted
calcium regulated
membrane,
membrane binding
basement
protein
matrix
annexin A3
NP_005130
J67
inhibitor of
phospholipase A2,
possesses anticoagulation
properties
annexin A5
AAH18671
J31, J32
cytoplasm
involved in signal
transduction and
apoptosis
annexin A6
AAH17046
J106
stress fibers
associates with
CD21 and regulates
the release of Ca
from intracellular
stores
calreticulin
AAP36116
J1
cytoplasm,
widely
probable
nucleus,
expressed oxidoreductase and
mitochondria
plays a role in
apoptosis
chloride
CAI17827
J64
membrane
chloride ion binding
intracellular
and transport
channel 1
enolase, gamma
AAA52388
J10, J11
cytoplasm
most adult
tissues
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glutathione Stransferase

CAA30894

J52, J53

glyceraldehyde-3phosphate
dehydrogenase

CAA25833

J30, J68,
J69, J70

heat shock 70
protein 5

NP_005338

J2

heat shock 70
protein 8
laminin-binding
protein
peroxiredoxin 2

NP_694881

J3, J4, J105

CAA43469

J17

CAA80269

J46

protein kinase
pyruvate kinase

CAI13015
CAA39849

J92
J104, J109

rho GDP
dissociation
inhibitor alpha
ribonuclease/angio
genin inhibitor
tubulin, alpha

AAP35530

J55

AAH00677

J9

CAA25855

tubulin, beta

0805287A

UMP-CMP kinase

AAH14961

J57, J58,
J92, J93
J6, J7, J8,
J65, J95
J51

vimentin

NP_003371

conjugates reduced
glutathione to
hydrophobic
electrophiles
catalyist for
carbohydrate
degradation and
glycolysis
involved in folding
and assembly of
proteins in the ER

cytoplasm

glucose
regulated
protein,
BiP,
dnaK-type
molecular
chaperone

involved in protein
folding
possibly involved in
cell adhesion
involved in redox
regulation; reduces
peroxides

cytoplasm
thiolspecific
antioxidant
protein

cytoplasm

kinase activity
catalytic enzyme in
carbohydrate
degradation and
glycolysis
regulates GDP/GTP
exchange reaction
of Rho proteins

cytoplasm

nucleus,
cytoplasm

J15, J16,
J22, J23,
J24, J25,
J26

ubiquitous

widely
expressed

Table 5-1E. Proteins identified from the soluble proteome of differentiated ARPE-19 cells.
Protein
NCBI
spot
synonym
subcellular
tissue
asscession
location
specificity
14-3-3
AAD48408
A52, A56
cytoplasm
ubiquitous
actin, beta

CAA45026

A25, A27,

cytoplasm
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ubiquitous

major constituent of
microtubules
major constituent of
microtubules
catalyzes
phosphoryl transfer
from ATP to UMP
and CMP
class three filaments
found in various
non-epithelial cells

function
involved in
regulation of
signaling pathways
involved in cell

alpha actinin

CAA38970

A28, A38,
A61, A62,
A63, A64,
A65, A66,
A67, A68,
A69, A70,
A73, A77,
A78, A79,
A80, A81,
A82, A84,
A94
A9

aminoacylase 1

AAH00545

A40

cytoplasm

annexin A5

AAH18671

A59, A60,
A62

cytoplasm

cathepsin B

2007265A

A74

lysosome

cathepsin D

AAP35556

A91

lysosome

cathepsin H

CAA30428

A104

lysosome

DJ-1 protein

NP_009193

A110

nucleus,
cytoplasm

widely
expressed

enolase, gamma

AAA52388

cytoplasm

most adult
tissues

filamin 1

NP_001447

A18, A46,
A47, A48,
49
A1, A2,
A3, A4,
A10, A11

actinbinding
protein280

cytoplasm

ubiquitous

FK506-binding
protein

AAC78853

A13

peptidylprolyl cistrans
isomerase

endoplasmic
reticulum

glutathione Stransferase

CAA30894

A87

glyceraldehyde-3phosphate
dehydrogenase

CAA25833

A98

heat shock protein
27

AAA62175

A109,
A111

motility

cytoplasm

cytoplasm

p24k-1,
estrogen
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cytoplasm,
nucleus

kidney,
brain,
placenta,
spleen

actin bundling
protein
involved in
hydrolysis of amino
acids
involved in signal
transduction and
apoptosis
degradation of
proteins
breaks down
proteins
degrades proteins in
lysosomes
positive regulator of
androgen receptordependent
transcription and
redox sensitive
chaperone

promotes branching
of actin filaments
and links actin
filaments to
membrane
glycoproteins
accelerates protein
folding during
protein synthesis
conjugates reduced
glutathione to
hydrophobic
electrophiles
catalyist for
carbohydrate
degradation and
glycolysis
involved in stress
resistance and actin

receptor
related
protein
lysyl hydroxylase
isoform 2

AAB58363

A35

phosphoglycerate
kinase 1

CAG32997

A85, A93,
A102,
A105

ribonuclease/angio
genin inhibitor
thioredoxin
domain containing
5

AAH00677

A21

NP_110437

A29

T-plastin
polypeptide
transglutaminase
triosephosphate
isomerase 1

AAB02844

A37

AAA63739
AAH17947

A54
A103

organization
endoplasmic
reticulum,
peripheral
membrane
protein

migrationinducing
gene 10
protein

majority
of
examined
cell types

cytoplasm

endoplasmic
reticulum
plastin-3

cytoplasm

variety of
organs

Table 5-1F. Proteins identified from the soluble proteome of human RPE cells.
protein
NCBI
spot
synonym
subcellular
asscession
location
14-3-3
AAD48408
K45, K46,
cytoplasm
K47

tissue
specificity
widely
expressed

actin, beta

CAA45026

ubiquitous

aldehyde
dehydrogenase 1

AAC51652

K61, K65,
K66, K67,
K68, K69,
K70, K71,
K95, K96
K11

annexin A4

NP_001144

K16

annexin A5

AAH18671

K44

cytoplasm

ATP synthase, H+
transporting,
mitochondrial F1
complex, beta

NP_001677

K91, K92

Mitochondrion

cytoplasm

cytoplasm
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forms
hydroxylysine
residues in
collagens for
carbohydrate
attachment
glycolytic enzyme
and primer
recognition protein

possesses
thioredoxin activity;
reduces insulin
disulfide bonds
actin bundling
protein

function
adapter protein
implicated in
regulating signaling
pathways
involved in cell
motility

binds free retinal
and CRALBPbound retinal; can
oxidize
retinaldehyde to
retinoic acid
promotes membrane
fusion and is
involved in
exocytosis
involved in signal
transduction and
apoptosis
catalyzes ATP
synthesis

subunit
calnexin

AAB29309

K73

calreticulin

AAP36116

K72

cytoplasm,
nucleus,
mitochondria

cathepsin D

AAP35556

lysosome

creatine kinase

AAC31758

K19, K20,
K30
K70, K71

cytoplasm

dihydropyrimidina
se-like 2
dynactin 2

AAH67109

K7

cytoplasm

NP_006391

K93

cytoplasm,
peripheral
membrane
protein

enolase, gamma

AAA52388

K64

cytoplasm

glutathione Stransferase

CAA30894

K24, K25,
K32, K34

glyceraldehyde-3phosphate
dehydrogenase

CAA25833

K52

guanine
nucleotide-binding
protein, beta 1

NP_002065

K18

heat shock 70
protein 5

NP_005338

K83

heat shock 70
protein 8
heat shock 90
protein 1
heat shock protein
27

NP_694881

K97

CAI20097

K82

AAA62175

K21, K31

cytoplasm

glucose
regulated
protein,
BiP,
dnaK-type
molecular
chaperone

p24k-1,
estrogen
receptor
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cytoplasm,
nucleus

widely
expressed

involved in calcium
ion binding
probable
oxidoreductase and
plays a role in
apoptosis
breaks down
proteins
reversibly catalyzes
the transfer of
phosphate between
ATP and various
phosphogens

ubiquitous
modulates
cytoplasmic dynein
binding to an
organelle and plays
a role in
prometaphase
chromosome
alignment and
spindle organization
most adult
tissues
conjugates reduced
glutathione to
hydrophobic
electrophiles
catalyist for
carbohydrate
degradation and
glycolysis
modulator of
various
transmembrane
signaling systems,
required for GTPase
activity
involved in folding
and assembly of
proteins in the ER

involved in protein
folding
involved in protein
folding
involved in stress
resistance and actin
organization

heat shock protein
gp96

AAK74072

K79

interphotoreceptor
matrix
proteoglycan 1
interstitial retinolbinding protein

CAI41298

K77

AAC18875

K78

lactate
dehydrogenase C

AAA59508

K15

peroxiredoxin 2

CAA80269

K26

phosphoprotein
phosphatase 2beta
prolilferation
inducing protein
15
protein disulfide
isomerase

B34541

K84

AAP82230

K39

BAA03759

K9, K81

protein kinase C
substrate
retinaldehydebinding protein

AAA98668

K74

NP_000317

K42, K43

rho GDP
dissociation
inhibitor alpha
tat binding protein
1

AAP35530

K35

AAB24840

K93

tat-associated

2110369A

K51

related
protein
glucoseregulated
protein
94,
GRP94,
tumor
rejection
antigen 1

endoplasmic
reticulum

molecular
chaperone that
functions in the
processing and
transport of secreted
proteins
found between RPE
and photoreceptor
cells
shuttles 11-cis and
all trans retinoids
between the RPE
and photoreceptor
cells
catalytic enzyme in
anaerobic glycolysis

Interphotoreceptor
matrix
Proliferationinducing
gene 19
protein
thiol
specific
antioxidant
protein

ferritin,
heavy
chain
Phosphorlipase c
alpha,
glucose
regulated
protein
CRALBP

cytoplasm

cytoplasm
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stores iron in a
soluble, nontoxic
form
catalyzes the
rearrangement of
disulfide bonds in
proteins

endoplasmic
reticulum

cytoplasm

cytoplasm
Proteasome
26S
ATPase

involved in redox
regulation; reduces
peroxides

cytoplasm

retina and
pineal
gland

regulatory subunit
of glucosidase II
carries 11-cis
retinol and 11-cis
retinaldehyde as
endogenous ligands
regulates GDP/GTP
exchange reaction
of Rho proteins
involved in the
ATP-dependent
degradation of
ubiquitinated
proteins

protein
tripeptidylpeptidase I

NP_000382

K14

tropomyosin 1

A23562

K48, K56

tropomyosin 4

NP_003281

K49, K53

tubulin, alpha

CAA25855

tubulin, beta

0805287A

K87, K88,
K89, K91
K89, K90

vimentin

NP_003371

ceroid
lipofuscinosis

K57, K58,
K60, K61,
K62

lysosome

widely
expressed

widely
expressed

lysosomal serine
protease
binds to actin
filaments
binds to actin
filaments
major constituent of
microtubules
major constituent of
microtubules
class three filaments
found in various
non-epithelial cells

Discussion
Proteomic Differences
There is a significant difference in the overall protein pattern observed on 2D gels
of the proteomes of differentiated and undifferentiated ARPE-19. The large difference in
protein patterns in these cells would seem to indicate that these cells are undergoing
significant changes in their protein composition as they differentiate. It also appears from
the protein pattern on 2D gels that UND and RPE cells have a more similar proteome
than DIF and RPE cells. This is also confirmed by the Venn diagrams, which show there
are indeed more proteins in common in the proteomes of UND and RPE cells than DIF
and RPE. These results are surprising, as one would expect the differentiated state to be
reflected in the morphology of the cells as well as in their proteomes. However, it would
appear that the factors contributing to the morphology and proteome are independent.
This may also suggest that the morphology of the cells is first affected upon
differentiation followed by proteomic variations and that these cells have not reached a
fully differentiated state. Another possibility is that the less abundant proteins in the cell,
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which are not observable on a 2D gel, maybe be the proteins which are significant
affected by the differentiation. To achieve a better understanding of the proteomic
changes that may be occurring in these cells further analysis of individual subcellular
fractionations would need to be examined.

Other Proteins of Interest
We examined the proteomes of these three cells for proteins that are vital to
proper functioning of the RPE. As previously mentioned, RPE cells are the most active
phagocytes in the body. To keep up with the phagocytosis and subsequent degradation of
photoreceptor discs, RPE cells contain numerous proteases. While cathepsin D was
identified in all three cell types, cathepsin B was only identified in UND and DIF.
However, two of the four proteases identified in these cells were specific to DIF and RPE
cells, cathepsin H and tripeptipdyl peptidase I, and the only cell type in which we
identified all four proteases was DIF cells.
One protein that functions in the renewal of 11-cis retinal and therefore is crucial
to proper functioning of the RPE is cellular retinaldehyde binding protein (CRALBP).
CRALBP was only identified in RPE cells which would indicate that although DIF cells
are undergoing significant changes, they have not achieved a fully differentiated state.

Phenotypic Differences
Of significant interest are the phenotypic characteristics of the differentiated
(DIF) and undifferentiated (UND) ARPE-19 cells as viewed by electron microscopy.
The UND ARPE-19 cells appear “flat” in comparison to the differentiated cells, which is
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consistent with other reports of the morphology of UND cells. These cells were also void
of microvilli on the apical surface. In contrast, microvilli are observable on the apical
side of DIF ARPE-19 cells. These cells also appear more cuboidal and stand ~8 μm from
the membrane. This is consistent with the report of Matsumoto, who observed
differentiated feline, monkey and human RPE cells, and in all three species the apical
surface of the cells was elevated 8-10μm above the substrate.[Matsumoto, 1990] These
morphological features would suggest that the DIF cells have made significant progress
towards achieving a differentiated state, although it would be difficult to assess the
degree of differentiation. Additional experiments focused on examining the tight
junctions and basal infoldings of these two cell types may provide further insight into the
differentiated state of these cells.
Because the morphological specializations associated with the surfaces of RPE
cells appear to be structural manifestations of functional requirements. We would
therefore suggest that the state of differentiation of RPE cells in vitro is an important
variable that needs to be considered when studying cellular events that depend on the
presence of specialized structures.
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